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ABSTRACT 
Thioester Hydrolysis Reactivity of Metal Complexes 
by 
James J. Danford, Master of Science 
Utah State University, 2009 
 
Major Professor: Dr. Lisa M. Berreau 
Department: Chemistry and Biochemistry 
 
 Glyoxalase II is one of two metalloenzymes found in the glyoxalase pathway and is 
responsible for catalyzing the hydrolysis of a thioester substrate. Its bimetallic active site is 
found to contain a variety of metal combinations, including Fe(III)Zn(II). A recent report 
indicates that human glyoxalase II, while containing a Fe(II)Zn(II) center, is catalytically 
active as a mononuclear Zn(II) enzyme. Detailed mechanistic studies of glyoxalase II 
enzymes are limited due to uncertainty in the metal ion content of recombinantly prepared 
samples. The research presented in this thesis is focused on gaining mechanistic insight 
into thioester hydrolysis promoted by well-characterized metal complexes  
The initial research is focused on studies involving a Fe(III)Zn(II) complex 
supported by the 2-{[bis(2-pyridylmethyl)amino]methyl}-6-[{[2-hydroxyphenyl)methyl]-
(2-pyridylmethyl)amino}methyl]-4-methylphenol) ligand. Thioester hydrolysis reactions 
were examined by following the loss of a deuterium-labeled thioester (hydroxyphenyl 
thioacetic acid S-methyl(d3) ester) over time using 2H NMR as the monitoring method. 
 
 
  iv  
Based on kinetic data and spectroscopic investigations (UV-vis and EPR), a reaction 
pathway for thioester hydrolysis promoted by the aforementioned Fe(III)Zn(II) complex 
has been proposed. An important feature of this pathway is the formation of a precursor 
complex wherein the deprotonated α-hydroxy group of the thioester coordinates to the 
Zn(II) center prior to nucleophilic attack by an Fe(III)-OH moiety.   
Of relevance to human glyoxalase II, the thioester hydrolysis reactivity of a 
mononuclear zinc complex containing the N,N-bis(2-pyridylmethyl)-tert-butylamine 
ligand, (bpta)Zn](ClO4)2⋅0.5H2O, has been examined. Based on kinetic data, it is proposed 
that thioester hydrolysis promoted by this complex proceeds via a bimolecular pathway, 
with a Zn-OH moiety being the nucleophile for attack on the thioester carbonyl. Activation 
parameters are reported for the zinc complex-promoted thioester hydrolysis reaction and 
are compared to those of OH- promoted thioester hydrolysis reactions. 
In a separate area of investigation, the chromium chloride complex 
{(C6H11N2)[CrCl3]}n  has been isolated and characterized by elemental analysis and X-ray 
crystallography. This complex has been proposed as the catalyst responsible for high yield 
conversion of glucose to 5-hydroxymethylfurfural (HMF), which is an important reaction 
toward using renewable resources as feedstock chemicals.  
 
                (161 pages) 
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CHAPTER 1 
INTRODUCTION 
METAL-PROMOTED HYDROLYSIS REACTIONS IN BIOLOGICAL  
AND MODEL SYSTEMS 
 
I. Background of Hydrolysis Chemistry 
Water (H2O) is a colorless, non-toxic compound, which can exist in three different 
physical states, depending on temperature and pressure. Water consists of 11% hydrogen 
and 89% oxygen by mass and covers approximately 70% of the earth’s surface. It is 
essential for life, as it accounts for at least 70% of the mass of cells in living organisms.1 
Hydrolysis is defined as a reaction that involves the ability of an ion(s) or 
compound(s) to react with water.1 Hydrolysis reactions are classified in several ways, 
depending on the area of study, including general acid-base chemistry, organic chemistry, 
inorganic chemistry, and biochemistry. General acid-base chemistry involves direct 
interaction of water with anions (X-) or protons (H+) (Scheme 1-1).1 In organic chemistry, 
hydrolysis is defined as a reaction that involves the conversion of one compound into two 
different species by the addition of water.2 There are numerous organic compounds, which 
have been shown to undergo either acid- or base-catalyzed hydrolysis, including esters, 
 
 
 
 
Scheme 1-1. Acid-base hydrolysis reactions. 
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Scheme 1-2. Ester, amide, and nitrile hydrolysis reactions. 
 
 
amides, and nitriles (Scheme 1-2).2 In inorganic chemistry, hydrolysis is defined as the 
reversible transfer of H+ from an aqua species, usually a metal-aqua complex (Scheme 1-
3).3 In biochemistry, hydrolysis is defined as the cleavage of a substrate (e.g. ATP), 
accompanied by the addition of the elements of water (Scheme 1-4).4 Hydrolysis reactions 
in biochemical systems are catalyzed by a variety of enzymes called hydrolases.3 Hydrolase 
enzymes possessing metal ions (metallohydrolases) are known to contain mononuclear, 
homobinuclear, and mixed binuclear metal centers at their active site. Among the 
metallohydrolase enzymes, metallo-β-lactamases, metalloaminopeptidases, alkaline 
phosphatases, and purple acid phosphatases are the most studied. Although Zn(II) is the 
most common active site metal ion in metallohydrolases, other metals found in these 
enzymes include Mn(II), Ni(II), Ca(II), and Mg(II).5 
 
 
 
Scheme 1-3. Hydrolysis chemistry of a metal-aqua complex. 
 
[M(H2O)6]
n+ H3O
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Scheme 1-4. Hydrolysis of adenosine triphosphate (ATP). 
 
 
In terms of hard/soft acid base theory, the metal ions found in metallohydrolases are 
classified as either hard Lewis acids [Mn(II), Mg(II), Ca(II)] or borderline Lewis acids 
[Zn(II) and Ni(II)]. An advantage of the latter ones is related to their ability to bind both 
hard and soft donor atoms. In biological systems, these interactions involve histidine, 
glutamate/aspartate, and cysteine ligands.6 The Lewis acidity of the metal ion is important 
for biological hydrolysis as it influences the pKa of metal-bound water molecules.7a   
In these enzymes, the metal center can play various roles in promoting hydrolysis 
reactions (Figure 1-1). The metal center can: (1) polarize chemical bonds (usually seen in 
the activation of carbonyls), which can lead to increased susceptibility of the carbonyl 
compound towards nucleophilic attack; (2) act as a Lewis acid to lower the pKa of a bound 
water molecule and produce a reactive hydroxide moiety; or (3) stabilize negative charge 
build-up in a transition state or intermediate formed during the hydrolysis reaction.8, 9  
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Figure 1-1.  Possible roles of a metal center in a hydrolysis reaction. 
 
II. Metallohydrolases, Models, and the Use of 
     Activated Ester Substrates 
a. Metallo-β-lactamases.  Metallo-β-lactamases (Class B β-lactamases) catalyze 
the hydrolytic ring opening of the β-lactam ring in all structural subtypes of antibiotics 
(penams, cephems, clavams, penems, and carbapenems) except monobactams, rendering 
them inactive (Scheme 1-5).10-17 These enzymes have been isolated from various bacteria 
including Bacteroides fragilis, Bacillus cereus, and Stenotrophomonas maltophilia. X-ray 
crystal structures of the metallo-β-lactamase enzymes from these sources have been shown 
to contain a binuclear zinc active site (Figure 1-2), though recent studies have indicated that 
the active form may utilize a single zinc ion.18-21 
 
 
 
 
 
Scheme 1-5. Hydrolysis of a β-lactam ring. 
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Figure 1-2. Active site features of metallo-β-lactamases. 
 
 
In terms of the bimetallic form, the proposed mechanism for β-lactam hydrolysis 
(Scheme 1-6) involves: (1) activation of the β-lactam carbonyl carbon through interaction 
with one of the Lewis acidic zinc centers; (2) nucleophilic attack by a Zn-OH moiety on the 
carbonyl carbon of the coordinated β-lactam, forming a tetrahedral intermediate; (3) C-N 
bond cleavage; and (4) protonation of the ring-opened nitrogen and release of the 
carboxylate to give the ring-opened product.22 In this mechanism, the role of the Zn2 site is 
to stabilize the ring-opened, deprotonated nitrogen. In the monozinc form, the proposed 
mechanism for β-lactam hydrolysis is similar, but with an aspartate residue acting as a 
general base/acid (Scheme 1-7).23  
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Scheme 1-6. Proposed mechanism of β-lactam hydrolysis by a binuclear zinc center. 
 
 
In an effort to probe metal binding in metallo-β-lactamase enzymes, 
heterobimetallic analogues (ZnNi, ZnCo, ZnFe) from E. coli have been overexpressed and 
purified.24-26 Studies have revealed that these analogues are reactive in the hydrolysis of β-
lactam substrates. Furthermore, research by Crowder and co-workers has shown that the 
metal content of these analogues is highly dependent on growth conditions.26 Additional 
research aimed at investigating inhibitors of metallo-β-lactamases has emerged and in the 
process, thiols have been identified as potential inhibitors of these enzymes.27-30 
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Scheme 1-7. Proposed mechanism of β-lactam hydrolysis by a mononuclear zinc center. 
 
 
b. Model studies of metallo-β-lactmases 
To provide further insight into the potential mechanism(s) by which these enzymes 
hydrolyze β-lactams, studies of benzylpenicillin and nitrocefin hydrolysis, promoted by 
synthetic binuclear zinc complexes (Figure 1-3), have been employed.31 Of particular  
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 Figure 1-3. Binuclear zinc complexes with relevance to β-lactamases. 
 
 
interest were studies conducted using complex 3. Infrared spectroscopic studies have 
shown that treatment of 3 with benzylpenicillin results in formation of a hydrolyzed, ring-
opened product (Scheme 1-8). To gain insight into how β-lactams interact with the 
binuclear zinc center of 3, X-ray crystallography, 13C NMR, and infrared spectroscopy of 3 
in the presence of oxazetidinylacetate were performed. These studies provided evidence 
supporting the hypothesis that coordination of the β-lactam to the zinc center occurs 
through the carboxylate group and not the carbonyl carbon of the β-lactam ring (Figure 1-
4).32 
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Scheme 1-8. Reaction of benzylpenicillin catalyzed by 3. 
  
 
 
 
 
 
 
 
 
 
Figure 1-4. Structural features of cationic portion of the (3)-β-lactam adduct. 
 
 
Another investigation focused on nitrocefin hydrolysis catalyzed by the binuclear 
zinc complex [Zn2(BPAN)(µ-OH)(µ-O2PPh2)](ClO4)2 (Scheme 1-9). This reaction results 
in the formation of a ring-opened product, as evidenced by a change in the λmax of 
nitrocefin from 390 nm to 486 nm.33 Kinetic studies as a function of the concentration of 
[Zn2(BPAN)(µ-OH)(µ-O2PPh2)](ClO4)2 revealed saturation behavior, which is consistent 
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Scheme 1-9. Hydrolysis of nitrocefin promoted by [Zn2(BPAN)(µ-OH)(µ-
O2PPh2)](ClO4)2. 
 
 
with substrate coordination to the metal complex prior to hydrolysis. The rate of hydrolysis 
increases with pH, yielding a kinetic pKa of 8.7, which is identical to the thermodynamic 
pKa determined by potentiometric titration. This pKa has been assigned to the deprotonation 
of a terminal zinc-bound water molecule in [Zn2(BPAN)(µ-OH)(H2O))](ClO4)2.34 These 
results provide evidence that the active nucleophile in nitrocefin hydrolysis is a terminal 
Zn-OH species.33  
Spectroscopic studies revealed that treatment of [Zn2(BPAN)(µ-OH)(µ-
O2PPh2)](ClO4)2 with cephalothin (an analog of nitrocefin) in DMSO causes a shift in the 
position of the carboxylate carbon 13C resonance and a shift in the carboxylate vC=O 
vibration band. These results are consistent with monodentate carboxylate coordination to 
the zinc center.33 Based on kinetic and spectroscopic studies, it has been proposed that 
nitrocefin hydrolysis promoted by [Zn2(BPAN)(µ-OH)(µ-O2PPh2)](ClO4)2 (Scheme 1-10) 
involves: (1) coordination of nitrocefin to one of the zinc centers; (2) nucleophilic attack by 
a terminal Zn-OH at the β-lactam carbonyl carbon, leading to formation of a tetrahedral 
intermediate; (3) C-N bond cleavage; and (4) release of the ring-opened product and 
regeneration of the dizinc species. 
S
O
N
H
N
O
S
O OH
O2N
NO2
S
O
N
H
HN
O
S
O OH
O2N
NO2
OH
9:1 H2O:DMSO
[Zn2(BPAN)]
  
 
    11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1-10. Proposed mechanism of nitrocefin hydrolysis promoted by [Zn2(BPAN)(µ-
OH)(µ-O2PPh2)](ClO4)2. 
 
 
c. Metalloaminopeptidases. Metalloaminopeptidases (MAPs) are a class of 
metallohydrolases that catalyze the hydrolytic cleavage of the N-terminal amino acid 
residue of polypeptide chains (Scheme1-11). Of the MAP enzymes that have been  
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Scheme 1-11. Cleavage of the N-terminal residue of a polypeptide chain by 
metalloaminopeptidases. 
 
 
characterized, leucine aminopeptidase (LAP) and the aminopeptidases isolated from 
Aeromonas proteolytica (ApAP) and Streptomyces griseus (SgAP) have been shown to 
possess an active site containing either one or two zinc centers.35-37 The X-ray crystal 
structure of ApAP indicates that the co-catalytic zinc centers are coordinated by histidine, 
glutamate, and aspartate ligands (Figure 1-5).38 
Kinetic, thermodynamic, spectroscopic, and additional X-ray crystallographic 
studies were conducted in order to gain insight into the mechanism of ApAP. Based on 
these studies, a mechanism for peptide hydrolysis (Scheme 1-12) has been proposed to 
involve: (1) coordination of the amide carbonyl oxygen to one of the zinc centers, followed 
by a shift of the bridging hydroxide to a terminal position on Zn1; (2) nucleophilic attack at 
the amide carbonyl carbon by a Zn-OH moiety and formation of a tetrahedral intermediate; 
(3) breakdown of the intermediate along with protonation of the amine leaving group; (4) 
C-N bond cleavage; and (5) release of the products.39 
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Figure 1-5. Active site of co-catalytic zinc centers in ApAP.  
 
 
d. Model Studies of Metalloaminopeptidases. Model studies aimed at obtaining 
mechanistic information relevant to metalloaminopeptidase enzymes have concentrated on 
the use of binuclear zinc complexes and the model substrate L-leucine-p-nitroanilide 
(LNA). These studies have shown that model binuclear zinc complexes possessing the 2,6-
bis[bis(2-methoxyethyl)aminomethyl]-4-X-phenol] ligand, where X = methyl, nitro, or 
chloro, mediate the hydrolysis of LNA (Scheme 1-13). The reactions were evaluated by 
monitoring the formation of the p-nitroaniline leaving group (λmax = 405 nm). The rate of 
hydrolysis was shown to increase with pH, yielding kinetic pKa values of 9.4 and 9.1 for 
the methyl and chloro species, respectively. These values have been assigned to the 
deprotonation of a Zn-OH2 to give a nucleophilic Zn-OH moiety.40-42 
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Scheme 1-12. Proposed mechanism of peptide hydrolysis catalyzed by ApAP.  For clarity, 
the zinc-coordinated amino acid ligands are shown only in the resting state (left).39 
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Scheme 1-13. Hydrolysis of LNA by three model binuclear zinc complexes. 
 
 
e. Alkaline Phosphatase. Alkaline phosphatase (AP) catalyzes the hydrolysis of 
phosphate monoesters under alkaline conditions (Scheme 1-14).43-53 Alkaline phosphatase 
is found in almost all organisms, however, it is the enzyme isolated from Escherchia coli 
(E. coli) that has been studied in great detail.54 This enzyme contains a binuclear zinc 
center in the active site (Figure 1-6), as well as a third metal center [Mg(II)].48,53,55 Debate 
has centered around the role of magnesium in AP enzymes and it has been proposed that a 
magnesium hydroxide moiety may act as a general base for the deprotonation of a 
neighboring serine-hydroxide (Ser-OH) moiety. This would lead to the formation of a 
nucleophilic serine-alkoxide moiety.50 
 
 
 
 
 
Scheme 1-14. Hydrolysis of phosphate monoesters by alkaline phosphatase. 
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Figure 1-6. Essential features of the active site of alkaline phosphatase. 
 
 
Mechanistic studies of the hydrolysis of phosphate monoesters catalyzed by 
alkaline phosphatase have been reported.7b,50,56 Based on these results, the mechanism 
(Scheme 1-15) is proposed to involve: (1) coordination of the phosphate monoester to the 
two zinc centers in a bridging fashion; (2) deprotonation of the Ser-OH; (3) nucleophilic 
attack by a Ser-O- species at the phosphorus, resulting in cleavage of the P-OR bond; (4) 
displacement of the zinc-bound alkoxide group by a water molecule, release of ROH, and 
formation of a new zinc hydroxide species; (5) nucleophilic attack at the phosphorus by the 
Zn-OH, resulting in cleavage of the P-O-Ser bond; (6) release of [HOPO3]2- and 
regeneration of the active site.  
f. Model Studies of Alkaline Phosphatase. Literature reports of binuclear zinc 
complexes with phosphate monoester hydrolysis reactivity relevant to AP enzymes are 
limited. One example is the hydrolytic reactivity of a binuclear zinc complex supported by  
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Scheme 1-15. Proposed mechanism for phosphate monoester hydrolysis catalyzed by 
alkaline phosphatase.  For clarity, the ligand environment of the zinc centers has been 
truncated.  
 
 
a macrocyclic cryptand ligand (Figure 1-7).57 X-ray crystallographic studies of this 
complex revealed that the two metal centers exhibit distorted trigonal bipyramidal 
geometries and are bridged by an alkoxide anion. Treatment of this complex with 4-
nitrophenyl phosphate in aqueous solution at 60 oC for two days results in the formation of 
the hydrolyzed product (4-nitrophenol) and a new, binuclear zinc-phosophoramide 
complex (Scheme 1-16).57 
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Figure 1-7. Binuclear zinc complex supported by a macrocyclic cryptand ligand. 
 
 
 
 
 
 
 
 
Scheme 1-16. Hydrolysis of 4-nitrophenyl phosphate promoted by a binuclear zinc cryptate 
complex. 
 
 
g. Purple Acid Phosphatases. Purple acid phosphatases (PAPs) constitute a family 
of binuclear metallohydrolase enzymes that catalyze the hydrolysis of phosphate 
monoesters (aryl phosphate monoesters, phosphoric anhydrides, and phosphoserine 
residues of phosphoproteins) under acidic or neutral conditions (Scheme 1-17).58-60 X-ray 
crystal structures of the various forms of PAP enzymes have revealed a bimetallic iron-
containing active site [Fe(III)M(II), M(II) = Fe, Zn, Mn] (Figure 1-8). The characteristic 
purple color found in PAP enzymes is due to a LMCT transition  
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Scheme 1-17. Hydrolysis of a phosphate monoester. 
 
 
 
 
 
 
 
 
Figure 1-8. Active site of purple acid phosphatases.  
 
 
(λmax = 510-560 nm, ε =  3000–4000 M-1 cm-1) involving the tyrosine ligand and the Fe(III) 
metal center.61-63 
PAP enzymes have been isolated from numerous sources including mammals, 
plants, and fungi. Mammalian PAPs are monomeric proteins with a molecular mass of 
approximately 35 kDa and contain a redox active diiron cluster at the active site.60 Plant 
PAPs can exist as either homo or heterodimers. A homodimeric plant PAP has been 
isolated having a molecular mass for each subunit of approximately 55 kDa. A 
heterodimeric plant PAP, isolated from tomato, possesses subunits of 63 kDa and 57 kDa. 
Less is known about fungal PAPs, however, a monomeric fungal PAP of approximately 85 
kDa has been isolated and purified from Aspergillus ficuum. Currently, the metal 
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composition of this enzyme is not known, however, it is proposed that the metal center may 
contain zinc, copper, or manganese.64 
The exact mechanism by which PAP enzymes hydrolyze phosphate monoesters is 
unknown, however, two mechanisms have been proposed (Scheme 1-18).60 In the first step 
of either mechanism it is proposed that the substrate coordinates to the metal center(s), yet, 
the mode by which coordination occurs (monodentate or bidentate) is highly debated.65,66 
Spectroscopic studies of the Fe(III)Zn(II) form isolated from bovine revealed that at the pH 
for catalysis (~6.5) the substrate coordinates to the divalent metal center in a monodentate 
fashion. Spectroscopic studies of the PAP enzyme obtained from pig revealed that at the 
pH for catalysis (~5) the substrate coordinates to the metal centers in a bridging bidentate 
fashion.67-70 Following substrate coordination to the metal center(s), nucleophilic attack by 
either a bridging or terminal hydroxide is proposed to occur, nevertheless, the nature of the 
active nucleophile is still a point of speculation. Studies conducted on PAP enzymes 
isolated from pig and red kidney bean have shown that at lower pH values (pH <5) enzyme 
activity increases. This increase in activity has been assigned to the formation of a terminal 
Fe(III)-OH species, which has been proposed to be the active nucleophile.65,71 In contrast, 
ENDOR studies and fluoride inhibition studies on pig and human PAP enzymes have 
argued against a terminal Fe(III)-OH being the active nucleophile. These studies have 
provided evidence to support the notion that the bridging hydroxide is the nucleophile for 
phosphate monoester hydrolysis.72-76 In the final step, the bound phosphate is proposed to 
dissociate from the metal center(s) and water molecules bind to regenerate the active site.77 
Depending on the pH, one or both of these new terminal water molecules may be in the 
hydroxide form. 
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Scheme 1-18. Proposed mechanisms of purple acid phosphatase enzymes. 
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h. Model Studies of Purple Acid Phosphatases. The active site of PAP enzymes 
contains two distinct metal coordination environments. Therefore, biomimetic studies of 
the properties of PAP enzymes have focused on the synthesis and characterization of 
heterobinuclear metal complexes possessing an asymmetric ligand environment. To date, 
the majority of model complexes of PAP enzymes have been generated using the 
asymmetric ligand H2L (L = 2-bis[{2-pyridyl-methyl)-aminomethyl}-6-{(2-hydroxy-
benzyl)-(2-pyridyl-methyl)}-aminomethyl]– 4 methyl-phenol) (Figure 1-9).74,78,79 Addition 
of one equivalent of the Fe(III) and M(II) salts [M = Zn, Fe, Mn, Cu, Ni] and two 
equivalents of sodium acetate to H2L in methanol generates the desired asymmetric 
heterobinuclear complexes (Figure 1-10). X-ray crystal structures of these complexes have 
shown that the Fe(III) center is coordinated to the terminal phenolate oxygen.74,78-84 Results 
of further research concerning the physical properties of these complexes are shown in 
Table 1-1. All complexes exhibit a characteristic purple color (λmax ~522 - 555 nm, ε = 
2600-4560 M-1 cm-1), which occurs due to a LMCT involving the phenolate oxygen and the 
Fe(III) center.78,79,81-83 Potentiometric titration measurements of the manganese, zinc, 
copper, and nickel complexes in a mixed solvent system [water:ethanol (30:70)] have 
provided multiple pKa values over the pH range of 3-9.78,79,81-83,85 In the case of the zinc, 
copper, and nickel complexes, three pKa values were obtained, however, in the manganese 
case only two were identified. Recent studies of the Fe(III)Zn(II) system have revealed a 
shift in the three pKa values when the solvent system was changed to water/acetonitrile 
(50:50).85   
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Figure 1-9. Ligand for PAP biomimics. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-10. Binuclear model complexes for PAP enzymes. 
OHN
N
OH
N
N
N
Fe(III) M(II)
ON
N
O
O O
O O
N
N
N
ClO4
-
M = Fe, Mn, Zn, Ni, Cu
  
 
    24 
Table 1-1. Selected physical properties of model complexes relevant to purple acid 
phosphatase enzymes. 
 
 
 
 
 
 
 
It has been proposed that upon addition of water to each complex, the bridging 
acetates dissociate from the metal center(s) and water molecules bind in their place. In the 
case of zinc, copper, and nickel, a water molecule coordinates at the terminal position on 
each metal center and a third water bridges the two metals. The first protonation 
equilibrium (lowest pKa) was assigned to the deprotonation of the bridging water molecule.  
The second protonation equilibrium was assigned to the deprotonation of the water 
molecule bound at the Fe(III) site, and finally deprotonation of the terminal water molecule 
bound at the M(II) site provides the final protonation equilibrium value (highest pKa) 
(Scheme 1-19).78,79,81-83,85        
Research conducted on PAP enzymes has shown that they are unable to hydrolyze 
biologically relevant phosphodiesters, as evidenced by their inability to hydrolyze bis(p-
nitrophenyl)phosphate (BpNPP).86 In contrast, model complexes designed to mimic the 
active site of PAP enzymes are able to hydrolyze biologically relevant phosphodiesters.83  
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Scheme 1-19. Protonation equilibria in aqueous/organic solution. 
 
 
 
Table 1-2. Kinetic parameters for the hydrolysis of BDNPP by PAP model complexes.60 
 
 
 
 
 
 
 
 
Kinetic parameters (Table 1-2) and mechanistic insight into phosphate hydrolysis has been 
obtained using the activated diester substrate 2,4-bis(dinitrophenyl) phosphate (BDNPP) 
(Figure 1-11).87 The results of these experiments indicate that the hydrolysis of BDNPP is 
highly dependent on the pH of the system and is optimal in the range of 6-7. In the case of  
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Figure 1-11. 2,4-bis(dinitrophenyl)phosphate. 
 
 
the Fe(III)Zn(II), Fe(III)Ni(II), and Fe(III)Mn(II) complexes, a terminal Fe(III)-OH is 
proposed to be the active nucleophile, while in the Fe(III)Cu(II) complex, the bridging 
hydroxide has been assigned as the active nucleophile.78,79,81-83 The debate about the exact 
mechanism of PAP enzymes continues and the significant differences shown in model 
systems, with regards to the coordination mode of BDNPP and the active nucleophile 
present during hydrolysis, has led to two proposed mechanisms (Scheme 1-20 and 1-21).  
In model complexes containing Fe(III)Zn(II), Fe(III)Mn(II), and Fe(III)Ni(II), the reaction 
is  proposed to involve: (1) coordination of BDNPP to the M(II) metal binding site in a 
monodentate fashion; (2) nucleophilic attack of the Fe(III)-OH at the phosphorus, resulting 
in the formation of a bridging species and a free alcohol; and (3) release of the phosphate 
and addition of water, leading to the regeneration of the active metal complex. For the 
model complex containing Fe(III)Cu(II), the reaction is proposed to involve: (1) 
coordination of BDNPP to the metal centers in a bridging bidentate fashion; (2) 
nucleophilic attack by the bridging hydroxide, resulting in the release of free alcohol; and 
(3) release of the phosphate and addition of water, leading to regeneration of the active 
metal complex. 
 
O
NO2
O2N
O
O
P NO2O
O2N
  
 
    27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
e
M
O
N
N
O
N
N
N
M
 =
 M
n
, 
Z
n
, 
N
i
O
H
2
O H
O
H
F
e
M
O
N
N
O
N
N
N
O H
O
H
PO
O
O
O
N
O
2
O
2
N
N
O
2
N
O
2
P O
O
O
O
N
O
2
N
O
2
N
O
2
O
2
N
F
e
M
O
N
N
O
N
N
N
O H
O
P
O
O
O
N
O
2
O
2
N
H
O O
2
N
N
O
2
O
PO O
O
N
O
2
N
O
2
2
 H
2
O
- 
H
2
O
S
c
h
e
m
e
 1
-2
0
. 
P
ro
p
o
se
d
 m
ec
h
a
n
is
m
 o
f 
p
h
o
sp
h
o
d
ie
st
er
 h
y
d
ro
ly
si
s 
p
ro
m
o
te
d
 b
y
 m
o
d
el
 F
e(
II
I)
Z
n
(I
I)
, 
F
e(
II
I)
N
i(
II
),
 a
n
d
 F
e(
II
I)
M
n
(I
I)
 c
o
m
p
le
x
es
.
  
 
    28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 
H
2
O
F
e
M
O
N
N
O
N
N
N
O
H
2
O H
F
e
M
O
N
N
O
N
N
N
O
O
PO
O
O
O
N
O
2
O
2
N
N
O
2
N
O
2
P
O
O
O
O
2
N
N
O
2
O
2
N
F
e
M
O
N
N
O
N
N
N
O
O
P
O
O
N
O
2
O
2
N
H
O O
2
N
N
O
2
O
PO O
O
N
O
2
N
O
2
2
 H
2
O
H
O
2
N
O
H
O
O
M
 =
 C
u
S
c
h
e
m
e
 1
-2
1
. 
P
ro
p
o
se
d
 m
e
c
h
a
n
is
m
 f
o
r 
h
y
d
ro
ly
si
s 
o
f 
B
D
N
P
P
 b
y
 F
e
(I
II
)C
u
(I
I)
 c
o
m
p
le
x
.
  
 
    29 
i. Activated Substrates. It has been shown that a convenient approach for 
investigating hydrolysis reactions in enzymatic and model systems is the use of “activated 
substrates” (Table 1-3).88 The term “activated” originates from the fact that the substrate(s) 
is more susceptible to nucleophilic attack during the hydrolysis reaction. Activation of the 
substrate is accomplished by introduction of strong electron withdrawing substituents. Of 
the various electron-withdrawing substituents available, the use of p-nitrophenyl leaving 
groups is preferred.  These leaving groups are ideal for investigating hydrolysis reactions 
because: (1) their conjugate acids possess low pKa values; and (2) they possess an 
absorption feature associated with the hydrolyzed p-nitrophenolate leaving group (λmax 
~400 nm), making hydrolysis easy to monitor by UV-Vis spectroscopy. 
 
 
Table 1-3. Hydrolysis of p-nitrophenyl substituted model substrates to the corresponding 
p-nitrophenolates. 
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III. Thioester Hydrolysis 
 The glyoxalase pathway (Scheme 1-22) is important for human health, as it is 
responsible for converting cytotoxic 2-oxoaldehydes (e.g. methylglyoxal 
(CH3C(O)C(O)H)) into nontoxic 2-hydroxy acids, utilizing glutathione (GSH) as an 
essential cofactor.89,90 Methylglyoxal is a reactive small molecule formed as a byproduct of 
lipid and carbohydrate metabolism.91 The toxicity of methylglyoxal arises from the 
reactivity of its aldehyde group with guanine residues of DNA and amino acid 
nucleophiles.92-96 Furthermore, methylglyoxal is found to be involved in the formation of 
advanced glycation end-products (AGE), which have been linked to aging and various 
diseases.97-99 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1-22. Glyoxalase pathway. 
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In the glyoxalase pathway two metalloenzymes, glyoxalase I (GlxI) and glyoxalase 
II (GlxII) can be found.  GlxI is responsible for the isomerization of a non-enzymatically 
formed hemithioacetal to a thioester.100,101 In the active site, GlxI contains a mononuclear 
metal center which, depending on the source, can be Zn(II) or Ni(II).102,103 GlxII is 
responsible for the hydrolysis of the enzymatically formed thioester to a 2-
hydroxycarboxylic acid and free glutathione.100 GlxII contains a binuclear metal center in 
the active site and is classified as a member of the β-lactamase superfamily of 
hydrolases.104, 105 
a. Glyoxalase I (GlxI). GlxI is a member of the metalloglutathione transferase 
superfamily and has been shown to play a crucial role in the detoxification of reactive 2-
oxoaldehydes. GlxI catalyzes the glutathione dependent isomerization of hemithioacetals to 
the corresponding 2-hydroxy thioesters (Scheme 1-23).106 GlxI enzymes have been isolated 
from various sources and the active site metal content is highly dependent on the source. 
GlxI enzymes isolated from bacterial sources (E. coli, Y. pestis, P. aeruginosa, and N. 
meningitides), as well as the enzyme isolated from the human parasite L. major have been 
found to contain a mononuclear Ni(II) center.107-110 By contrast, GlxI enzymes isolated 
from human and yeast sources have been shown to contain a mononuclear Zn(II) center.111-
114 
X-ray crystal structures of the Ni(II)-dependent GlxI enzyme from E. coli and the 
Zn(II)-dependent GlxI enzyme from humans have revealed a distorted octahedral geometry 
around the metal centers (Figure 1-12). The Ni(II)-dependent GlxI is ligated by two 
 
VIII. Reaction of 
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Scheme 1-23. Isomerization of hemithioacetal to thioester. 
 
 
histidines, two glutamates, and two water ligands. The Zn(II)-dependent GlxI is ligated by 
one histidine, two gluatamate, one glutamine, and two water molecules.98 Depending on the 
metal ion present, different mechanistic pathways have been proposed for the isomerization 
of a hemithioacetal substrate to the corresponding thioester. In Zn(II)-dependent GlxI 
enzymes (Scheme 1-24), the mechanistic pathway is suggested to first involve the loss of 
two water molecules, followed by a bidentate coordination of the substrate to the metal 
center. Deprotonation of the substrate at the C1 carbon leads to the formation of an enediol.  
This is followed by protonation of the C2 carbon leading to the formation of a bound 
thioester. Finally, the addition of two equivalents of water releases the thioester and 
regenerates the active site.98,115 In the Ni(II)-dependent GlxI enzyme (Scheme 1-25), the 
mechanistic pathway is suggested to involve a Ni(II)-OH species. First, one of the nickel-
bound water molecules is deprotonated, leading to the formation of a Ni(II)-OH moiety.  
The Ni(II)-OH species extracts a proton from the C1 carbon of the hemithioacetal, leading 
to the formation of an enolate species. Protonation of the enolate at the the C2 carbon yields 
the thioester.116,117 
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Figure 1-12. Active site of Zn(II) and Ni(II)-dependent GlxI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1-24. Proposed mechanism for Zn(II) catalyzed isomerization of hemithioacetal. 
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Scheme 1-25. Proposed mechanism for Ni(II) catalyzed isomerization of a hemithioacetal. 
 
 
b. Glyoxalase II (GlxII). GlxII is a member of the metallo-β-lactamasesuperfamily 
of hydrolase enzymes and catalyzes the final step in the glyoxalase pathway.118 GlxII 
hydrolyzes a thioester to a 2-hydroxy carboxylic acid and free glutathione (Scheme 1-26). 
GlxII enzymes have been isolated from various sources including human and plant.118-126 
The most detailed studies reported to date on GlxII enzymes have been conducted on those 
isolated from human sources and the plant Arabidopsis thaliana.127-136 
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Scheme 1-26. Hydrolysis of a thioester to a 2-hydroxy carboxylic acid. 
 
 
c. Human Glyoxalase II (human GlxII). X-ray crystallographic characterization 
of the human GlxII enzyme has shown the presence of a binuclear metal center in the 
active site (Figure 1-13). The two metal centers (M1 and M2) are separated by 3.3 to 3.5 Å 
and each possesses a coordination number of five. The M1 site is ligated by three histidines 
(His-54, His-56, His-110), a bridging water/hydroxo moiety, and a single oxygen donor 
from a bridging aspartate ligand (Asp-134). The M2 site is coordinated by two histidines 
(His-59, His-173), one terminal aspartate (Asp-58), one bridging aspartate (Asp-134), and a 
bridging water/hydroxo moiety.120 The metal binding domain in human GlxII is similar to 
that present in metallo-β-lactamases.120 Metal analysis of the protein used for the X-ray 
experiment showed the presence of ~1.5 moles of zinc and ~0.7 moles of iron per mole of 
protein.120 Despite this metal content, researchers initially assigned human GlxII as a dizinc 
metalloenzyme due to the similar metal binding domain between GlxII and metallo-β-
lactamases. Based on this assumption, a mechanism was proposed for thioester hydrolysis 
(Scheme 1-27).120 In this mechanism, the bridging hydroxide acts as a nucleophile and 
 
R = CH3,
 Ph, etc.
SG = Glutathione
GlxII
Hydrolysis
R C
OH
C
O
OH
H
+ GSHR C
OH
C
O
SG
H
  
 
    36 
 
 
 
 
 
 
 
Figure 1-13. Active site of human GlxII. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1-27. Proposed mechanism for a dizinc-containing human GlxII. 
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attacks the carbonyl carbon of the thioester and the Zn1 center stabilizes the tetrahedral 
transition state. Cleavage of the C-S bond results in the formation of the 2-hydroxy 
carboxylic acid and free glutathione.   
In 2009, Crowder et al. reported that human GlxII contains an Fe(II)Zn(II) center in 
vivo, but is catalytically active as a mononuclear Zn(II) enzyme. Therefore, it has been 
proposed that the second metal binding site is not essential to catalysis.137  
d. Mitochondrial and Cytoplasmic Glyoxalase II (Glx2-5 and Glx2-2) from 
Arabidopsis thaliana. X-ray crystallographic characterization of a recombinantly produced 
mitochondrial GlxII (Glx2-5) from Arabidopsis thaliana (Figure 1-14) has shown that the 
coordination environment of each metal center differs from that found in human GlxII. The 
M1 site has a tetrahedral geometry and is ligated by three histidine donors (His-54, His-56, 
His-112) as well as a bridging water/hydroxide ligand. The M2 site has a trigonal 
bipyramidal geometry and is ligated by two aspartates (Asp-58, Asp-131), two histidines 
(His-59, His-169), and a bridging water/hydroxide.119 Essentially, while human GlxII has a 
bridging aspartate ligand, this carboxylate is terminal on the M2 site in Glx2-5. 
Metal analysis of the recombinantly produced Glx2-5 enzyme from Arabidopsis 
thaliana, grown under conditions of excess iron and zinc (supplemented media), revealed 
that the enzyme contained ~1.0 mole of iron, ~1.3 moles of zinc, ~0.016 moles of 
manganese, and <0.001 moles of copper. However, Glx2-5 overexpressed in a non-
supplemented media resulted in the enzyme containing approximately equal amounts of 
iron and zinc (~0.6 moles) and no detectable amounts of either manganese or copper. EPR 
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Figure 1-14. Active site of mitochondrial GlxII from Arabidopsis thaliana. 
 
 
studies of Glx2-5 grown in supplemented media suggested the presence of two major 
species. The first was assigned to the Fe(III)Zn(II) moiety and constituted ~70% of the 
EPR signal. The second was assigned to the Fe(III)Fe(II) moiety and constituted the 
remaining 30% of the EPR signal.119 
A cytoplasmic glyoxalase II (Glx2-2) from Arabidopsis thaliana has been 
overexpressed and purified. The sequence comparison of Glx2-2 with the metal binding 
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center of metallo-β-lactamases are conserved in Glx2-2.125 Based on these results, the  
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Figure 1-15. Proposed active site of Glx2-2. 
 
 
water molecule. The M2 site is ligated by two aspartates (Asp-139, Asp-226), one histidine 
(His-272), a bridging water/hydroxide, and a terminal water molecule.125    
Metal analysis of a wild type cytoplasmic GlxII (Glx2-2) revealed the enzyme to 
contain ~0.8 moles of zinc and ~1.5 moles of iron per mole of protein. These results 
suggest that either zinc or iron can occupy the metal binding sites.128 Further studies 
conducted on the wild type Glx2-2 grown in rich media showed that the enzyme contains 
various amounts of zinc, iron, and manganese. Based on EPR, mass spectrometry, and X-
ray absorption spectroscopy, Glx2-2 has been proposed to contain various heterogeneous 
and/or homogeneous combinations of metals in the active site, including Fe(III)Zn(II), 
Fe(III)Fe(II), Zn(II)Zn(II), Fe(II)Fe(II), Mn(II)Mn(II), Fe(III)Mn(II), Fe(II)Mn(II),  and 
Zn(II)Mn(II).124 Based on these findings, a new mechanism for thioester hydrolysis has 
been proposed (Scheme 1-28).128 This mechanism involves: (1) coordination of the 
substrate to the metal center(s) (a proximal arginine (Arg-248) can help to orientate the 
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thioester); (2) the bridging hydroxide between the iron and zinc centers becomes terminal 
on the Fe(III) site; (3) nucleophilic attack by a Fe(III)-OH at the carbonyl carbon, results in 
the formation of a tetrahedral transition state; (4) release of D-lactic acid; and (5) 
protonation of the thiolate and release of glutathione leads to the regeneration of the active 
site. 
e. Model studies of Glyoxalase II enzymes. To date, no glyoxalase II enzyme has 
been produced containing only one type of bimetallic combination. This situation presents 
an ideal opportunity for model studies involving model complexes, in which specific metal 
ion content is known. In 2006, the Berreau laboratory reported the first examples of zinc 
hydroxide complexes (Figure 1-16) capable of mediating thioester hydrolysis.138 
Complexes 1 and 2 are binuclear in the solid state, however, in acetonitrile solution they 
dissociate into mononuclear species. Treatment of either zinc complex with 
hydroxyphenyl-thioacetic acid S-methyl ester (Figure 1-17), at 45 oC in acetonitrile 
resulted in the formation of methanethiol (H3CSH) and a zinc-bound mandelate 
complex.138 Additional studies were conducted to determine whether a binuclear zinc 
complex possessing a bridging hydroxide (Figure 1-18) could promote thioester hydrolysis. 
Treatment of this complex with hydroxyphenyl-thioacetic acid S-methyl ester at 45 oC in 
acetonitrile for ~3 days resulted in no hydrolysis products being observed.138 From these 
results, the authors hypothesized that a bridging hydroxide moiety is not sufficiently 
nucleophilic to react with a thioester substrate, and that a terminal metal-hydroxide is 
required in order for thioester hydrolysis to occur. 
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Figure 1-16. Binuclear zinc hydroxide complexes. 
 
 
 
 
 
 
Figure 1-17. Hydroxyphenyl-thioacetic acid S-methyl ester. 
 
 
 
 
 
 
 
 
Figure 1-18. Binuclear zinc complex with a bridging hydroxide ligand. 
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The research presented in Chapters 2 and 3 of this thesis centers around gaining 
insight into the metallohydrolase enzyme Glyoxalase II (GlxII). The research presented 
focuses on thioester hydrolysis reactivity studies of binuclear and mononuclear metal 
complexes of relevance to GlxII enzymes. Chapter 2 describes thioester hydrolysis 
reactivity promoted by the binuclear complex [(BPBPMP)Fe(III)Zn(II)(µ-OAc)2]ClO4, 
which is used to mimic the Fe(III)Zn(II) form of Glyoxalase II enzymes. The results 
presented in this chapter provide mechanistic insight into thioester hydrolysis promoted by 
the mentioned metal complex in a mixed organic/aqueous solution, over the pH range of 7-
9. Chapter 3 investigates thioester hydrolysis reactivity promoted by the mononuclear zinc 
complex [Zn(bpta)](ClO4)2, which is used to mimic the mononuclear Zn(II) form of human 
Glyoxalase II enzymes. Further information describing the synthesis, and characterization 
of this complex are outlined. Kinetic studies and activation data for the thioester hydrolysis 
reaction in a mixed organic/aqueous solution promoted by [Zn(bpta)](ClO4)2 are offered. 
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CHAPTER 2 
THIOESTER HYDROLYSIS REACTIVITY OF AN FE(III)ZN(II) COMPLEX* 
 
Abstract 
 Glyoxalase II enzymes catalyze the hydrolysis of a thioester substrate and have 
been found to coordinate a variety of dimetal combinations, including Fe(III)Zn(II), within 
the enzyme active site. Of relevance to these enzymes, the thioester hydrolysis reactivity of 
the Fe(III)Zn(II) compound [(BPBPMP)Fe(III)Zn(II)(µ-OAc)2]ClO4 (1) was evaluated in 
CH3CN:H2O (50:50; buffered) at 26.5 °C. Thioester hydrolysis in the absence and presence 
of 1 was monitored using 2H NMR by following the loss of the thioester –SCD3 signal. 
Two products are generated in the reaction involving the metal complex, CD3SSCD3 and 
CD3SH. Kinetic studies of this reaction as a function of pH revealed maximum rate above 
the pKa of a Zn-OH2 moiety of [(BPBPMP)Fe(III)(OH)(µ-OH)Zn(II)(OH2)]+, which forms 
from 1 in CH3CN:H2O (50:50). UV-vis and EPR studies of a single turnover thioester 
hydrolysis reaction in the presence of one equivalent of 1 at pH = 9.0 suggest that the 
thioester does not initially interact with the Fe(III) center, but that changes occur at this site 
over the course of the reaction. The formation of a Fe(III)–SCD3 moiety is proposed. This 
proposal is based on the observed CD3SSCD3 formation and a decrease in the intensity of  
the g = 4.3 feature over the course of the single turnover thioester hydrolysis reaction. The 
latter suggests reduction of a portion of the Fe(III) to Fe(II), which is consistent with 
                                                
*Coauthored by James J. Danford, Piotr Dobrowolski, and Lisa M. Berreau. Reproduced 
with permission from Inorg. Chem. 2009, 48, 11352-11361. Copyright 2009 American 
Chemical Society. 
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disulfide formation. A mechanism for thioester hydrolysis is proposed involving initial 
coordination of the deprotonated α-hydroxy thioester to the zinc center followed by 
nucleophilic attack by a terminal Fe(III)-OH moiety and thiolate leaving group stabilization 
by the Fe(III) center. Overall, this study outlines a novel approach of using an aliphatic 
thioester substrate and 2H NMR to provide mechanistic insight into thioester hydrolysis 
involving an Fe(III)Zn(II) complex of relevance to glyoxalase II. 
 
Introduction 
 Metallohydrolases containing an active site heterobinuclear metal cluster are an 
area of intense current investigation.1,2 Falling within this classification are some 
glyoxalase II (GlxII) enzymes, which have been identified as containing a bimetallic 
iron/zinc cluster that catalyzes thioester hydrolysis.3 GlxII is a member of the metallo-β-
lactamase superfamily of proteins4 and is one of the two metalloenzymes found in the 
ubiquitous glyoxalase pathway.5 The primary physiological substrate of the glyoxalase 
pathway (Figure 2-1) is believed to be methylglyoxal (CH3C(O)CHO), a small molecule 
byproduct of lipid and glucose metabolism that is cytotoxic and mutagentic.5-8 GlxII 
catalyzes the hydrolysis of a S-(2-hydroxyacyl)glutathione thioester (SLG) to produce the 
corresponding S-2-hydroxyacid and free glutathione (Figure 2-1). As SLG is also cytotoxic 
and can inhibit DNA synthesis,5,9 the reaction catalyzed by glyoxalase II is important in 
cellular detoxification.10 Elevated levels of GlxI and GlxII mRNA and protein have been 
reported in tumor cells, and inhibitors of the glyoxalase system have been shown to affect 
tumor growth in vitro.11 For this reason, several studies have been reported toward the 
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Figure 2-1. (Top) Glyoxalase pathway. (Bottom) Active site structural features in  
crystallographically characterized GlxII enzymes. 
 
design of anti-tumor agents that target the glyoxalase system.10a,11,12  
 Glyoxalase II enzymes from a variety of sources have been characterized by X-ray 
crystallography.3b,3c,13 In each structure the active site contains a binuclear metal cluster in 
which each metal center is coordinated by three terminal amino acid ligands, a bridging 
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aspartate, and a bridging water/hydroxide moiety. In a subset of the X-ray structures, a 
bridging carboxylate or a terminal water molecule occupies the sixth coordination position 
on each metal center. The active site structural features of GlxII enzymes are similar to 
purple acid phosphatase in that one metal site has three terminal neutral donors and the 
second site contains a terminal anionic oxygen donor ligand.2d 
 A problem that has hampered comprehensive mechanistic studies of the GlxII-
catalyzed thioester hydrolysis reaction is the variable metal ion content of GlxII enzymes 
which depends on the source of the enzyme and preparation conditions.3,13,14 Specifically, 
different amounts of iron, zinc, and manganese ions are incorporated into the active site 
binuclear cluster depending on conditions. Metal ion contents that have been proposed on 
the basis of spectroscopic studies and metal analyses in GlxII enzyme samples include 
Fe(III)Zn(II), Fe(II)Zn(II), Fe(III)Fe(II), Zn(II)Zn(II), Fe(II)Fe(II), and Mn(II)Mn(II).3,13,14 
For the mitochondrial Arabidopsis thaliana GlxII produced recombinantly in E. coli in rich 
media, the predominant iron-containing form of the enzyme (~70%) is proposed to have an 
Fe(III)Zn(II) metal ion content.3c 
 Neves and coworkers previously reported the Fe(III)Zn(II) complex 
[(BPBPMP)Fe(III)Zn(II)(µ-OAc)2]ClO4 (1, Figure 2-2) which, when dissolved in 
CH3CN:H2O (50:50), exhibits three pKa values.2a These have been assigned to the 
deprotonation of a bridging water molecule, a terminal Fe(III)-OH2, and a terminal Zn(II)-
OH2, indicating that the bridging acetate ligands are displaced in favor of water ligands in 
aqueous solution. A structurally relevant species to the proposed Fe(III)(H2O)(µ-  
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Figure 2-2. Solution properties of 1 in CH3CN:H2O (50:50). 
 
 
 
OH)Zn(II)(H2O) complex, [(BPBPMP)Fe(III)(H2O)(µ-OH)Zn(II)](ClO4)2 (2), has been 
crystallized from a methanol:H2O solution and characterized by X-ray crystallography.2e In 
1:1 CH3CN:H2O, this compound exhibits pKa values of 2.93, 4.81, and 8.30. These have 
been assigned to similar ionizations to those depicted in Figure 2-2. X-ray absorption 
spectroscopic studies of 2 in CH3CN:H2O (70:30) provided evidence that both metal 
centers are six-coordinate in solution. 
 To our knowledge, no thioester hydrolysis reactivity studies involving an 
Fe(III)Zn(II) complex of relevance to GlxII have been reported. To address this deficiency, 
we report herein our initial studies of the thioester hydrolysis reactivity of the Fe(III)Zn(II) 
complex 1 in a CH3CN:H2O (buffered) solution. Our approach involves the use of 2H NMR 
as a monitoring technique to follow the loss of a deuterium-labeled thioester. This method 
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has allowed us to examine the reactivity of an aliphatic α-hydroxy thioester of structural 
relevance to the glutathione adduct of the glyoxalase pathway. We note that only one study 
of thioester hydrolysis promoted by a metal complex has been previously reported.15 This 
investigation, which involved binuclear zinc compounds and reactivity studies in organic 
solvent, suggested the need for a terminal Zn-OH for thioester hydrolysis.  
 
Experimental Section 
 General and Physical Methods. All reagents and solvents were obtained from 
commercial sources and were used as received unless otherwise noted. When necessary for 
synthetic procedures, solvents were dried according to published procedures16 and were 
distilled under N2 prior to use.  IR spectra were recorded on a Shimadzu FTIR-8400 as KBr 
pellets. 1H NMR spectra for characterization purposes were recorded in CD3CN at ambient 
temperature on a JEOL ECX-300 or Bruker ARX-400 NMR spectrometer. 1H NMR 
parameters appropriate for paramagnetic complexes were used for obtaining spectra of 1.17 
Chemical shifts (in ppm) are referenced to the residual solvent peak in CHD2CN (1H: 1.94 
(quintet)). 2H NMR spectra were collected as previously described and were referenced to 
an internal standard of C6D6 (7.16 ppm).17 ESI/APCI mass spectra were obtained at the 
University of California, Riverside. UV-vis spectra were recorded on a Hewlett-Packard 
HP8453 diode array spectrophotometer at ambient temperature. EPR spectra were collected 
at 5(1) K using a Bruker EMXPlus spectrometer system fitted with a continuous flow 
liquid helium cooled cyrostat. Elemental analyses were performed by Atlantic Microlabs of 
Norcross, GA.  
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 Synthesis of Ligand Precursors. The organic precursors 2,6-bis-(chloromethyl)-
4-methylphenol,18 bis-(2-pyridylmethyl)amine,19 and (2-hydroxybenzyl)(2-
pyridylmethyl)amine20 were synthesized according to literature procedures with minor 
modifications. 
 Synthesis of Hydroxyphenyl Thioacetic Acid S-methyl(d3) Ester 
(PhCH(OH)C(O)SCD3). This d3-labeled thioester was prepared according to literature 
procedures starting from d6-DMSO.21 1H NMR (CD3CN, 300 MHz): δ 7.41-7.35 (m, 5H), 
5.22-5.20 (d, J = 5.2 Hz, 1H), 4.46-4.44 (d, J = 5.2 Hz, 1H, O-H) ppm; 13C{1H} NMR 
(CD3CN, 100.6 MHz) δ 204.7, 140.4, 129.8, 129.7, 128.0, 80.3, 11.6 (7 signals expected 
and observed); 2H NMR (CH3CN, 61.4 MHz) δ 1.92 (s, pwhh ~3 Hz); 2H NMR 
(CH3CN:H2O (50:50, buffered, pH = 9.0)) δ 1.92 (s, pwhh ~4 Hz); FTIR (KBr, cm-1) 3441 
(νOH), 1682 (νC=O); Anal calcd for C9H7D3SO2: C, 58.35; H+D, 5.39. Found: C, 58.48; 
H+D, 5.49.  
 Synthesis of 2-{[bis(2-pyridylmethyl)amino]methyl}-6-[{[2-
hydroxyphenyl)methyl]-(2-pyridylmethyl)amino}methyl]-4-methylphenol (L1).22 To a 
solution of 2,6-bis(chloromethyl)-4-methylphenol (14.4 g, 0.0702 mol) in dry CH2Cl2 (500 
mL) was added a solution of (2-hydroxybenzyl)(2-pyridylmethyl)amine (9.14 g, 0.0427 
mol) in dry CH2Cl2 (55 mL) and triethylamine (19.6 mL, 0.141 mol). The reaction mixture 
was stirred overnight (~12 h). At this point, bis-(2-pyridylmethyl)amine was added (22.4 g, 
0.113 mol) and the solution was allowed to stir for an additional 24 h at room temperature. 
The solution was then transferred to a separation funnel and 300 mL of brine solution was 
added. The mixed aqueous/organic solution was extracted with CH2Cl2 (3 x 100 mL). The 
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combined organic fractions were then dried over sodium sulfate and the solvent was 
removed under reduced pressure to produce a brown solid. Purification of this solid by 
column chromatography on silica gel using a 4:1:1 ratio of ethyl 
acetate:hexanes:triethylamine as the eluent yielded a white powder (Rf ~ 0.50; Yield: 9.21 
g, 40%); (CDCl3, 400 MHz) δ 8.57-8.56 (m, 3H), 7.61-6.81 (m, 15H), 3.90 (s, 8H), 3.80 (s, 
2H), 3.75 (s, 2H), 2.27 (s, 3H) ppm. The 1H NMR of L1 matched that previously reported.22  
 CAUTION!  Perchlorate salts of metal complexes with organic ligands are 
potentially explosive. Only small amounts of material should be prepared, and these should 
be handled with great care.23 
 [(L1Fe(III)Zn(II)(µ-O2C2H3)2]ClO4  (1). A procedure for the preparation of 1 has 
been previously reported.2f In our hands this procedure resulted in the formation of a 
significant amount of the Fe(III)Fe(II) complex as detected by 1H NMR.24 To a methanol 
solution of L1 (50.0 mg, 0.0920 mmol) was added a methanol solution of Me4NOH⋅5H2O 
(33.3 mg, 0.184 mmol). The reaction was stirred for ~5 minutes, at which time a methanol 
solution of Zn(ClO4)2⋅6H2O (34.1 mg, 0.0920 mmol) was added, followed by a methanol 
solution of Fe(ClO4)3⋅6H2O (42.4 mg, 0.0920 mmol). The resulting mixture became dark 
purple and was stirred for approximately 2 minutes, at which point a methanol solution of 
NaOAc (15.0 mg, 0.184 mmol) was added. This mixture was stirred for 1 h and then the 
solvent was removed under reduced pressure. The remaining solid was dissolved in CH2Cl2 
and solution was passed through a celite/glass wool plug. The filtrate was pumped to 
dryness and the remaining solid was recrystallized 3-4 times from MeOH at room 
temperature. FTIR (KBr, cm-1) 3441 (νN-H), 1597 (νCOO), 1435 (νCOO), 1096 (νClO4) 764 
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(νClO4). ESI/APCI-MS, m/z (relative intensity), 781.15 ([M-ClO4]+, 100%). Anal calcd. for 
C38H39N5FeZnClO10⋅1.5H2O: C, 50.27; H, 4.67; N, 7.72. Found: C, 50.15; H, 4.65; N, 7.63.  
 Thioester Hydrolysis Monitored by 2H NMR. Product Identification. A 0.75 mL 
solution comprised of CH3CN (0.30 mL), buffer solution (0.36 M CHES, 0.30 mL) 
containing NaNO3 (I = 0.61 M), and doubly distilled H2O (0.15 mL) was prepared. An 
internal chemical shift standard (C6D6, 1 µL) was added and the pH of this solution was 
adjusted to pH = 9.0 using 0.1 M NaOH. To this solution was added a 0.15 mL solution of 
the hydroxyphenylthioacetic acid S-methyl(d3) ester in CH3CN (2.0 mg dissolved in 1.0 
mL, 0.011 M). The resulting mixture was transferred to an NMR tube and the tube was 
placed in a Bruker ARX NMR probe which had been previously optimized for 2H data 
collection at 26.5°C. Over the course of >450 h, the intensity of the 1.92 resonance of the 
thioester –SCD3 group decreased while a new resonance appeared at 2.12 ppm. This 
product was confirmed as CD3SH by identification of its volatility (purging the solution 
with N2 results in loss of the 2.12 ppm resonance) and by a positive Ellman’s reagent test, 
which indicates the presence of a free thiol. Similar experiments were performed with 
appropriate buffers at pH = 7.0, 7.5, 7.9, and 8.6. In each case, the only product was 
CD3SH.  
 For the reaction involving the metal complex, a similar reaction mixture was 
prepared, with 1 (variable concentration) dissolved in the CH3CN portion. For these 
reactions, as the intensity of the 1.92 ppm signal decreases, two new resonances appear at 
2.18 and 2.12 ppm, respectively. The resonance at 2.18 ppm was identified as being from 
the disulfide CD3SSCD3 by comparison of the chemical shift to that of CH3SSCH3 in 50% 
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D2O:CD3CN (2.18 ppm). The resonance at 2.12 ppm was identified as belonging to a 
volatile species (e.g. CD3SH) by purging the reaction mixture with N2, which results in the 
loss of this resonance. Similar product mixtures were identified at all pH values (7.0, 7.5, 
7.9, 8.6, 9.0).   
 Kinetic Measurements. General procedure for background reactions 
involving only PhCH(OH)C(O)SCD3. Reaction mixtures were prepared in an identical 
manner to that outlined for the qualitative NMR experiments described above. The pH of 
each solution was adjusted to the desired value using 0.1 M NaOH. To this solution was 
added a 0.15 mL solution of the hydroxyphenylthioacetic acid S-methyl(d3) ester in CH3CN 
(2.0 mg dissolved in 1.0 mL, 0.011 M). The resulting mixture was transferred to an NMR 
tube and the tube was placed in a Bruker ARX NMR probe which had been previously 
optimized for 2H data collection. 2H NMR spectra were collected at 26.5 ˚C as a function of 
time and were referenced to the chemical shift of the C6D6 standard (δ = 7.16 ppm). The 
progress of the reaction was monitored by observing the loss of the –SCD3 resonance for 
the starting thioester at 1.92 ppm. Data was collected until >80% of the thioester had 
undergone reaction. Data was collected for a minimum of two runs at pH 8.6 and 9.0. 
Background data at lower pH values was collected for only one run due to the slow nature 
of the hydrolysis reaction (kobs ~10-7 - 10-8 s-1). Background observed rate constants are: pH 
= 7.0 (5.7 x 10-8 s-1), pH = 7.5 (9.2 x 10-8 s-1), pH = 7.9 (1.5 x 10-7 s-1), pH = 8.6 (1.2(1) x 
10-6), pH = 9.0 (1.1(1) x 10-6 s-1).  
 Kinetic Measurements. General procedure for reactions containing 1 and 
PhCH(OH)C(O)SCD3. A 0.75 mL solution comprised of 1 in CH3CN (0.30 mL), buffer 
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solution (0.30 mL) containing NaNO3 (I = 0.61 M), and doubly distilled H2O (0.15 mL) 
was prepared. An internal chemical shift standard (C6D6, 1 µL) was then added. The pH of 
this solution was adjusted to the desired value using 0.1 M NaOH. To this solution was 
added a 0.15 mL solution of the hydroxyphenylthioacetic acid S-methyl(d3) ester in CH3CN 
(2.0 mg dissolved in 1.0 mL, 0.011 M). The resulting mixture was transferred to an NMR 
tube and the tube was placed in a Bruker ARX NMR probe which had been previously 
optimized for 2H NMR data collection. Each 2H NMR spectrum was referenced to the 
chemical shift of the C6D6 standard (δ = 7.16 ppm). Each reaction was monitored by 
observing the loss of the -SCD3 resonance for the starting thioester at 1.92 ppm as a 
function of time until the reaction was >80% complete. As the intensity of the 1.92 ppm 
signal decreases, two new resonances appear at 2.18 and 2.12 ppm, respectively. The 
resonance at 2.18 ppm was identified as being from CD3SSCD3 by comparison of this 
chemical shift to that of CH3SSCH3 in 50% D2O:CD3CN (2.18 ppm). The resonance at 
2.12 ppm was identified as belonging to a volatile species (e.g. CD3SH) by purging the 
reaction mixture with N2, which results in the loss of this resonance. The initial 
concentration of metal complex was varied from 9.0 x 10-4 M to 0.018 M. Data was 
collected for a minimum of two runs at all metal complex concentrations and pH values.  
 Deconvolution of 2H NMR data for the reactions involving 
PhCH(OH)C(O)SCD3.  Integrated intensities of the –SCD3 resonances in the 2H NMR 
kinetic data were determined using a Lorentzian-Gaussian curve fitting program provided 
in the Delta NMR Software v 4.3.6 package (JEOL, Ltd). For each spectrum acquired, the 
chemical shift of the resonance of C6D6 was set to 7.16 ppm. The integrated intensity of the 
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HDO resonance at 3.95 ppm was set to one deuteron. The concentration of –SCD3 labeled 
thioester was then determined via integration of the 1.92 ppm resonance versus the HDO 
integrated intensity. Pseudo first-order rate constants were determined from slopes of plots 
of ln[thioester] versus time. Typical correlation coefficients for these plots were ≥ 0.98. 
 UV-vis Experiments. (A) A solution of 1 (0.008 mmol) was prepared in CH3CN 
(15 mL), buffer solution (10 mL) containing NaNO3 (I = 0.61 M), and doubly distilled H2O 
(5 mL). The absorption spectrum of this solution was then measured. The entire solution 
was then added to solid PhCH(OH)C(O)SCD3 (0.008 mmol) and the absorption spectrum 
was again recorded. (B) An identical solution of 1 to that described in part (A) was 
prepared. This solution was then added to solid mandelic acid (0.008 mmol) and the 
absorption spectrum was again recorded. (C) An NMR sample of the thioester hydrolysis 
reaction mixture, judged complete by 2H NMR, was diluted from 1.8 x 10-3 M to 2.67 x 10-
4 M in terms of 1, and an absorption spectrum was obtained.   
 EPR Experiments. A single turnover thioester hydrolysis reaction in the presence 
of 1 (2.67 x 10-4 M) in 50:50 CH3CN:H2O (CHES buffer, pH = 9, I = 0.61 M (NaNO3)) 
was monitored by removal of aliquots for EPR experiments. Each aliquot was immediately 
frozen at 77 K prior to EPR data acquisition at 5(1) K.  
 
Results 
 Investigating Thioester Hydrolysis Promoted by an Fe(III)Zn(II) complex.  
Rationale for the use of a deuterium-labeled thioester and 2H NMR. We have initiated our 
studies using an Fe(III)Zn(II) complex (1, Figure 2-2) that has previously been shown to 
catalyze the hydrolysis of the activated phosphate diester 2,4-bis(dinitrophenyl)phosphate 
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(BDNPP) in mixed organic/aqueous solution.2f This complex contains pyridyl and 
phenolate ligation to the Fe(III) center, resulting in intense ligand based absorption features 
below 350 nm and a broad phenolate→Fe(III) LMCT centered at ~464 nm (pH = 9.0, ε 
~2500 M-1cm-1). Typically, hydrolysis reactions promoted by metal complexes (e.g. Zn-OH 
complexes) are investigated using an activated p-nitrolabeled substrate and UV-vis 
spectroscopy as the monitoring method.25 This approach is not feasible for investigating 
thioester hydrolysis reactions promoted by 1 for several reasons. First, the absorption 
maximum of the p-nitrothiophenolate leaving group of NO2-C6H4-SC(O)CH3 (λmax = 410 
nm) overlaps to some extent with the LMCT of 1. A more important issue is the low pKa of 
the p-nitrothiophenolate leaving group (pKa = 4.5),26 which means that thioester bond 
scission in buffered aqueous solution at pH ≥ 7 at ambient temperature is fast relative to 
that of the oxygen analog (p-nitrophenolate, pKa = 7.15)27 in the absence of any metal 
complex. The presence of a methylene unit in the thioester NO2-C6H4-CH2SC(O)CH328 
gives a leaving group with a higher pKa value (8.87), which therefore should produce a 
slower thioester hydrolysis reaction. However, the absorption maximum for the p-
nitrobenzylthiolate leaving group is at 360 nm, which is within a region that also contains 
intense absorption features for the Fe(III)Zn(II) complex 1. Additional methods that have 
previously been employed in studying thioester hydrolysis reactions in enzymatic systems 
also are not feasible for reactions involving 1. For example, for kinetic studies involving 
glyoxalase II enzymes, thioester hydrolysis is monitored using the substrate S-D-
lactoylglutathione, which is converted to reduced glutathione and D-lactic acid. The rate of 
hydrolysis of this substrate is followed by measuring the loss in absorbance of the substrate 
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at 240 nm (ε = 3100 M-1cm-1).13b For thioesterase enzymes, reactions are typically 
monitored by continuous assays based on the use of thiol derivatizing agents (e.g. Ellman’s 
reagent, 5,5’-dithio-bis(2-nitrobenzoic acid) DTNB) that yield colored products (λmax = 412 
nm).29 In considering thioester hydrolysis model reactions involving 1, both of these 
approaches used in enzymatic systems would be problematic due to overlap of the product 
absorption feature with absorption bands of the metal complex.   
 In the experiments outlined herein we have used a deuterium-labeled thioester 
PhCH(OH)C(O)SCD3 and 2H NMR to examine thioester hydrolysis in the absence and 
presence of 1 (Scheme 2-1). The use of this particular thioester is especially relevant to the 
chemistry of glyoxalase II enzymes as PhCH(OH)C(O)SCD3 contains an α-hydroxy group 
and alkyl thiol leaving group (CD3SH), both of which are found in glyoxalase II substrates 
(Figure 2-1). The hydrolysis products of this reaction in the pH range examined (7.0-9.0) 
should be mandelate anion (pKa = 3.85)27 and CD3S-/CD3SH (CH3SH, pKa = 9.7).30 As 
outlined below, in addition to the production of CD3SH we have identified the formation of 
the disulfide CD3SSCD3 in reaction mixtures involving the Fe(III)Zn(II) complex 1.  
 
 
 
 
Scheme 2-1. General reaction parameters for thioester hydrolysis using 2H NMR. 
 Product Identification in Thioester Hydrolysis Reactions Involving 
PhCH(OH)C(O)SCD3. Mild heating of a solution of PhCH(OH)C(O)SCD3  in 50:50 
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CH3CN:H2O (CHES buffer, I = 0.61 M) at pH = 9.0 at 26.5 °C results in the gradual 
disappearance of the –SCD3 resonance of the starting thioester at 1.92 ppm and the 
appearance of a new resonance at 2.12 ppm (Figure 2-3). The new species produced is 
volatile, as purging of the reaction mixture with N2 at room temperature results in loss of 
this 2.12 ppm resonance. Based on the volatility of this product, and a positive Ellman’s 
reagent test for free thiol at the conclusion of the reaction, we formulate this product as 
CD3SH. As can be seen in Figure 2-3, the thioester hydrolysis reaction involving 
PhCH(OH)C(O)SCD3 requires >400 h to reach greater than 80% completion. The 
formation of mandelate as the other product in the thioester hydrolysis reaction mixture is 
proposed based on stoichiometry and our previous study of thioester hydrolysis involving 
zinc complexes using the same substrate wherein the formation of mandelate was identified 
using spectroscopic and analytical approaches.15 Performing the thioester hydrolysis 
reaction in the presence of 1 (2.5 eq relative to thioester) under identical conditions gives 
2H NMR spectra containing two product resonances (2.18 and 2.12 ppm; Figure 2-4). The 
species at 2.18 ppm was identified as the disulfide D3CSSCD3 via comparison of the 
chemical shift of this resonance with that of H3CSSCH3 in 50:50 CD3CN:D2O. This 
disulfide product should be generated from CD3S-, as alkylthiolates are known to undergo 
catalytic oxidation in the presence of O2 and Fe(III).31 For example, Fe(III)-EDTA in the 
presence of O2 has been shown to catalyze the oxidative coupling of n-butyl thiol to give 
the disulfide in 93% yield in aqueous methanol (pH = 9.5). Overall, the thioester hydrolysis 
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Figure 2-3. 2H NMR spectra of a background thioester hydrolysis reaction collected as a 
function of time. Conditions: 50:50 CH3CN:H2O, pH = 9.0 (0.36 M CHES buffer), I = 0.61 
M (NaNO3), [PhCH(OH)C(O)SCD3] = 1.8 x 10-3 M, 26.5 °C. 
 
 
reaction in the presence of 2.5 equivalent of 1 is considerably faster than the background 
reaction, requiring <2 h to go to >80% completion. It is important to note that in the 
presence of 0.5 eq of 1 relative to the thioester, the hydrolysis reaction was found to 
proceed to completion, indicating catalytic turnover occurs under the reaction conditions. 
Thus, pseudo first-order conditions are present even at low concentrations of metal 
complex.  
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Figure 2-4. 2H NMR spectra of a thioester hydrolysis reaction in the presence of 1 
collected as a function of time. Conditions: 50:50 CH3CN:H2O, pH = 9.0 (0.36 M CHES 
buffer), I = 0.61 M (NaNO3), [PhCHC(O)SCD3] = 1.8 x 10-3 M, [1] = 4.5 x 10-3 M, 26.5 
°C.  
 
 
 Kinetic Studies and Effect of pH. The thioester hydrolysis reaction was 
monitored as a function of the concentration of the metal complex (0-10 eq relative to 
thioester) at pH = 7.0-9.0. The disappearance of the 1.92 ppm resonance of the thioester 
was monitored as a function of time. As can be seen in Figures 2-3 and 2-4, the 2H NMR 
spectra involve peak widths for the –SCD3 resonances of the starting thioester and resulting 
products (pwhh ~4 Hz) that are broad relative to standard 1H NMR resonances. These 
broad peak widths required the use of curve-fitting to deconvolute peak overlap and 
determine accurate integration values for the 1.92 ppm thioester resonance. Fitting of the 
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loss of the thioester versus time to a single exponential equation yielded pseudo first-order 
rate constants for each reaction. In the absence of 1, the pseudo first-order rate constant for 
the thioester hydrolysis reaction at pH = 9.0 is 1.1(1) x 10-6 s-1. In the presence of 2.5 
equivalents of 1, the pseudo first-order rate constant is 2.3(2) x 10-4 s-1, indicating a >200-
fold rate enhancement. Rate constants for other pH values in the presence of 2.5 
equivalents of 1 are given in Table 2-1. For all pH values, a rate enhancement of at least 
140-fold was identified relative to the background hydrolysis reaction. As shown in Figure 
2-5, at all pH values plotting of the first-order rate constant versus [1] yielded a saturation 
curve wherein for low concentrations of 1 the rate of the reaction initially increased 
linearily. However, at higher concentrations of metal complex, the rate becomes 
independent of [1] indicating a rate-determining step that is more complicated than a single 
step. This kinetic behavior is consistent with a mechanism wherein an equilibrium step (K1) 
precedes an irreversible step (k2). Fitting of the pH = 9.0 data to eq. 1 yielded K1 = 42(24) 
and k2 = 1.8(6) x 10-3 s-1. The K1 value indicates a weak interaction of the thioester with the 
metal complex. The pH dependence on the rate of thioester hydrolysis for reactions 
containing 2.5 equivalents of 1 is shown in Figure 2-6. The data is fit to eq. 4 derived for a 
monoprotic system (Figure 2-7) and yields a kinetic pKa value of 8.8. This value is similar 
to the thermodynamic pKa (8.3) previously report by Neves, et al. for the Zn-OH2 moiety in 
the solution form of [(BPBPMP)Fe(III)(H2O)(µ-OH)Zn(II)](ClO4)2 (2),2e indicating that 
the maximum rate is obtained upon formation of a Zn-OH unit. We note that data cannot be 
collected at higher pH values using the 2H NMR approach as the reaction proceeds too 
rapidly at 26.5 °C. 
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Table 2-1. Observed rate constants for thioester hydrolysis promoted by 1.a 
 
 
pH kobs (s-1) 
7.0 1.10(2) x 10-5 
7.5 1.69(6) x 10-5 
7.9 2.49(26) x 10-5 
8.6 1.63(9) x 10-4 
9.0 2.31(20) x 10-4 
                                      aConditions: 50:50 CH3CN:H2O, 0.36 M  
                                 MOPS or CHES buffer, I = 0.61 M (NaNO3),  
                                       [PhCHC(O)SCD3]= 1.8 x 10-3 M 
 
 
 
 
 
 
 
 
 
 
Figure 2-5. Plot of [1] versus kobs for the thioester hydrolysis reaction. Conditions: 50:50 
CH3CN:H2O, pH = 7.0-9.0 (0.36 M MOPS or CHES buffer), I = 0.61 M (NaNO3), 
[PhCHC(O)SCD3] = 1.8 x 10-3 M, 26.5 °C.   
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                                 M, [1] = 4.5 x 10-3 M, 26.5 °C. 
 
 
 
 
 
 
 
Figure 2-6. Dependence of kobs on the pH of the reaction mixture. Conditions: 50:50 
CH3CN:H2O, [buffer] = (0.36 M MOPS or CHES), I = 0.61 M (NaNO3), 
[PhCHC(O)SCD3] = 1.8 x 10-3 M, [1] = 4.5 x 10-3 M, 26.5 °C. 
 
 
 
 
 
Figure 2-7. Equations describing the pH dependence of the thioester hydrolysis reaction 
involving 1. 
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 Spectroscopic Investigations of the Thioester Hydrolysis Reaction. In order to 
gain further insight into the reaction pathway of thioester hydrolysis promoted by 1, a 
single turnover reaction was monitored by UV-vis and EPR. 
 UV-vis Experiments. A solution of 1 (1.8 x 10-3 M) identical to that used in the 
kinetic studies at pH = 9.0 and containing one equivalent of thioester was prepared and 
immediately diluted using CH3CN:H2O (0.36 M CHES buffer, I = 0.61 M NaNO3) to [1] = 
2.67 x 10-4 M for UV-vis spectral analysis. The features of the spectrum in the region of 
300-850 nm are identical to that found for 1 in the absence of thioester under identical 
conditions (Figure 2-8). Of particular importance, no change is seen in the position or 
intensity of the terminal phenolate-to-Fe(III) LMCT at ~464 nm, which indicates that the 
thioester does not interact with the Fe(III) center. 
 The absorption spectrum obtained at the conclusion of the single turnover thioester 
hydrolysis reaction differs from the starting reaction mixture, with an increase in intensity 
at ~400 nm and the phenolate–to-Fe(III) LMCT being less distinct. To evaluate whether the 
mandelate product interacts with the metal complex, a solution of 1 (2.67 x 10-4 M in 
CHES buffer (pH = 9), I = 0.61 M (NaNO3)) was prepared containing one equivalent of 
mandelic acid. This produces an absorption maximum at ~440 nm, which is somewhat 
similar to that found for the solution of the reaction products. As disulfide is generated in 
the thioester hydrolysis reaction mixture, which suggests that some reduction of Fe(III) to 
Fe(II) could be occurring, we also examined the absorption spectra of analytically pure 1 in 
the presence of equimolar amounts of sodium dithionite and mandelic acid. This produced 
a shift in the absorption maximum similar to the solution containing mandelic acid, but  
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Figure 2-8. UV-vis absorption spectra.  Conditions: 50:50 CH3CN:H2O, [buffer] = 0.36 M 
CHES, I = 0.61 M (NaNO3), [1] = 2.67 x 10-4 M, 26.5 °C. 
 
 
with a slightly lower intensity. Overall, the UV-vis experiments suggest that changes are 
occurring at the Fe(III) center over the course of the reaction, with coordination of 
mandelate being a possibility. 
 The other product of the thioester hydrolysis reaction, CD3S-, may also coordinate 
to the metal complex. For this reason, we introduced one equivalent of NaSCH3 into a 
solution of 1 in CH3CN:H2O (2.67 x 10-4 M in CHES buffer (pH = 9.0), I = 0.61 M 
(NaNO3)). This produced no shift in the absorption maximum of the complex. Addition of 
another 6 equivalents of NaSCH3 also produced no change in the absorption spectrum. 2H 
NMR analysis of a solution of 1 and one equivalent of NaSCD3 in CH3CN:CHES buffer at 
pH = 9.0 (I = 0.61 M) revealed the formation of CD3SH. Thus, free thiolate is rapidly 
converted to thiol in the reaction mixture. 
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 EPR experiments. A reaction mixture was prepared as outlined for the 2H NMR 
kinetic studies. This mixture was then immediately diluted to [1] = 2.67 x 10-4 M using 
CH3CN:H2O (0.36 M CHES buffer, I = 0.61 M NaNO3). Using UV-vis to evaluate reaction 
progress (at this concentration the single turnover reaction takes ~120 h to go to 
completion), aliquots were removed at specified intervals and frozen at 77 K. EPR spectra 
were then collected at 5(1) K. Selected spectra are shown in Figure 2-9. Upon introduction 
of the thioester (90 sec) a spectral change is identifiable wherein the intensity of the g = 9 
and g = 4.3 features increased, whereas a decrease in intensity is found for the feature at g 
= 6.6. We note that it has been previously reported that the addition of 2,4-BDNPP to 
[(BPBPMP)Fe(III)(H2O)(µ-OH)Zn(II)](ClO4)2 (2) in acetonitrile:HEPES buffer at pH = 
7.0 produces an increase in the g = 9 and g = 4.3 features similar to that identified here.2f 
The data for the phosphate diester 2,4-BDNPP was interpreted as indicating that the 
phosphate ester monoanion did not directly interact with the Fe(III) center, and instead 
coordinated in a monodentate fashion to the Zn(II) center. One possible explanation for the 
initial EPR features of both systems is that in the absence of a substrate molecule there is a 
portion of the compound that exists as a dimer ([Fe(III)Zn(II)]2 with J > hν for 
Fe(III)…Fe(III) coupling) and is EPR silent and a portion that is a monomer 
([Fe(III)Zn(II)] which gives an EPR signal. Upon reaction with the thioester or phosphate 
diester the proportion of the monomeric species is enhanced. Alternatively, the changes in 
the spectra upon addition of thioester could be due to changes in the zero field splitting  
parameters (i.e. D) for the S = 5/2 Fe(III) center.32 Overall, the similarity of the EPR 
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Figure 2-9. EPR spectra obtained at various intervals in the single turnover thioester 
hydrolysis reaction promoted by 1. All spectra were recorded at 5(1) K using 1.0 mW 
microwave power, 100 kHz modulation frequency, 0.814 mT field modulation amplitude, 
and a 20.3 mT/s sweep rate. 
 
 
spectral changes for the thioester and phosphate diester reactions suggests similar 
interactions with the metal complex. 
 In the thioester hydrolysis reaction a second intermediate maximizes in intensity at 
49 h (Figure 2-9). This species is characterized by a feature at ~850 G (g ~8), with a 
residual feature still present at g ~9. Overall, the EPR spectrum did not cleanly convert  
 
 
  78 
  
 
 
 
 
 
Figure 2-10. EPR spectrum of 1 in the presence of one equivalent of mandelic acid. The 
spectrum was recorded at 5(1) K using 1.0 mW microwave power, 100 kHz modulation 
frequency, 0.814 mT field modulation amplitude, and a 20.3 mT/s sweep rate. 
 
 
back to exactly that of the starting complex after 168 h (g ~8 feature still present). In 
addition, the g = 4.3 signal in the final spectrum is less intense and broadened compared to 
that of the starting material. This may be due to the reduction of a portion of the Fe(III) to 
Fe(II) over the course of the reaction. 
 An EPR spectrum of analytically pure 1 in the presence of one equivalent of 
mandelic acid ([1] = 2.67 x 10-4 M using 50:50 CH3CN:H2O (0.36 M CHES buffer, I = 
0.61 M NaNO3)) revealed a spectrum with g ~6.4, 4.3, and 2.0 (Figure 2-10). The distinctly 
different nature of this spectrum versus that of 1 under identical conditions (Figure 2-9) 
indicates that the mandelate anion interacts with the Fe(III)Zn(II) complex in the absence 
of thioester or its hydrolysis products. However, for the single turnover thioester hydrolysis 
reaction mixture, a spectrum containing a significant g ~6.4 feature is not produced at any 
 
  79 
time interval (Figure 2-9). Importantly, this indicates that following thioester hydrolysis the 
coordination properties (e.g. available coordination sites) of the Fe(III)Zn(II) complex have 
been altered. We hypothesize that this is due to coordination of CD3S-, or structural 
changes resulting from a Fe(III)-SCD3 interaction. When produced near the Fe(III) center, 
the thiolate anion could be stabilized via metal coordination. As noted herein, formation of 
a Fe(III)-SCD3 adduct is a logical precursor to the observed formation of the disulfide 
D3CSSCD3. 
 Proposed Mechanism. Based on literature precedent,2e,2f and the kinetic and 
mechanistic data presented above, we propose a mechanism for thioester hydrolysis 
promoted by 1 as outlined in Scheme 2-2. Saturation kinetic behavior is found for the 
thioester hydrolysis reaction at pH = 7.0-9.0, with maximum rate being produced above the 
pKa of the Zn-OH2 moiety (pH > 8.3).2e Saturation kinetic behavior was also found for the 
phosphate diester hydrolysis reaction promoted by 1, which occurs with a pH optimum of 
6.5. The lack of change in the UV-vis and EPR spectral features found upon the 
introduction of thioester to 1 at pH = 9.0 is similar to the data reported for the introduction 
of phosphate diester to 1 at pH = 7.0.2e This suggests that for both types of substrates 
(thioester or phosphate diester monoanion) similar chemistry is occurring, albeit at 
different pH values. On this basis, we propose that at pH = 9.0 ligand exchange occurs at 
the zinc center via deprotonation of the α-hydroxy group of the thioester to give an 
equilibrium amount of a zinc alkoxide species.33 Formation of such an alkoxide adduct is 
proposed based in part on the fact that at pH = 9.0 no coordination position is available on  
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Scheme 2-2. Proposed reaction pathway for thioester hydrolysis promoted by 1. 
 
 
the Zn(II) center in the absence of reaction with the Zn(II)-OH moiety. Importantly, an 
alkoxide type structure is also proposed to form in the borate-catalyzed hydrolysis of an α-
hydroxy thioester (Scheme 2-3), wherein a borate-substrate complex is formed followed by 
intramolecular attack of a boron-coordinated OH- to form a tetrahedral transition state.34 
For the Fe(III)Zn(II) complex, attack of the terminal Fe(III)-OH moiety on the thioester 
carbonyl could lead to the formation of a tetrahedral transition state from which the –SCD3  
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Scheme 2-3. Proposed mechanism for borate-catalyzed α-hydroxythioester hydrolysis.34  
 
 
leaving group could be stabilized via coordination to the Fe(III). The formation of a Fe(III)- 
SCD3 unit can serve as the precursor for the observed formation of the disulfide 
D3CSSCD3. Specifically, the proposed mechanistic pathway for disulfide formation 
catalyzed by Fe(III) complexes involves Fe(III)-SR ligation prior to a redox process that 
results in the formation of Fe(II) and RS⋅.31 Coupling of two RS⋅ species gives the disulfide 
product, and oxidation of the Fe(II) to Fe(III) via reaction with O2 could regenerate 1. 
Alternatively, the Fe(III)-SR species may undergo protonation and ligand displacement to 
give CD3SH (pKa ~ 9.7) and 1. Based on independent EPR experiments, the mandelate 
anion does not interact with the Fe(III)Zn(II) complex following thioester hydrolysis. We 
hypothesize that the coordination properties of the Fe(III)Zn(II) complex are affected by 
the formation of the Fe(III)-SCD3 entity. However, the observed turnover, as reaction 
mixtures containing 0.5 eq of 1 promote thioester cleavage in >80% yield, is consistent 
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with regeneration of at least a portion of the Fe(III)-OH moiety either by protonation and 
release of CD3SH, or oxidation of an Fe(II)Zn(II) complex by O2. 
 
Discussion 
 The glyoxalase pathway, by mediating the chemical modification of 
methylglyoxal, is directly involved in preventing the biosynthesis of advanced glycation 
end-products (AGEs), which are associated with aging and disease mechanisms.35 Both 
enzymes of the glyoxalase pathway (Figure 2-1) are metalloenzymes, with glyoxalase I 
containing either Zn(II) or Ni(II) depending on the source,10b and glyoxalase II containing a 
variety of bimetallic combinations as described herein. Despite the health relevance of this 
pathway, very few studies involving synthetic complexes of relevance to the glyoxalase 
pathway have been reported.15,21b,36 
 The active site of the Fe(III)Zn(II) form of glyoxalase II has similarity to the active 
site of purple acid phosphatase (PAP).2d,37 Specifically, they have in common a divalent 
metal binding site comprised of three neutral donors, and a second metal binding site with 
one terminal carboxylate ligand. In both glyoxalase II and PAP the metal centers are 
bridged by a carboxylate and a hydroxide ligand. Due to this structural similarity, 
[(BPBPMP)Fe(III)Zn(II)(µ-OAc)2]ClO4 (1),2f which has been used in model studies of PAP 
enzymes, is an appropriate starting point for an investigation of thioester hydrolysis 
reactivity.  
 At pH values below the pKa of the Zn-OH2 in 1, the observed saturation kinetic 
behavior (pH = 7.0, 7.5, 7.9; Figure 2-5) is consistent with a reaction pathway that involves 
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Scheme 2-4. Proposed mechanism for thioester hydrolysis promoted by 1 at pH values  
below the pKa of the Zn-OH2 moiety.  
 
 
coordination of the thioester carbonyl moiety to the Zn(II) center via displacement of water 
(Scheme 2-4). Attack of the Fe(III)-OH on the thioester could then lead to a tetrahedral 
transition state and subsequent product formation. This reaction pathway is very similar to 
that proposed by Zang et al. for the Fe(III)Zn(II) containing form of the cytoplasmic 
glyoxalase II from Arabidopsis.3f In this mechanism, Zang and coworkers suggested that 
the (His)3-ligated metal site (M1, Figure 2-1) activates the metal carbonyl, with the M2 site 
(Figure 2-1) being the source of a terminal hydroxide nucleophile and also assists in 
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stabilizing the transition state and thiolate leaving group. Our results support the notion that 
the Fe(III) site (M2 in the Fe(III)Zn(II) form) could provide the nucleophilic hydroxide and 
stabilize the thiolate leaving group in the thioester hydrolysis reaction. Reaction 
mechanisms proposed for the dizinc form of human glyoxalase II based on the X-ray 
structure13a and computational studies38 suggest that a bridging hydroxide can serve as the 
nucleophile to attack the thioester, with the M2 site serving to stabilize the transition state 
and the thiolate leaving group.38  
 We propose that the increased rate found above the pKa of the Zn-OH2 moiety in 
reactions involving 1 is associated with anionic coordination of the α-hydroxy thioester to 
the Zn(II) center. The reactivity of Zn-OH species with alcohols has been previously 
investigated.39 Using mononuclear zinc complexes supported by a hydrophobic 
hydrotris(pyrazolyl)borate ligand, Parkin and coworkers found that more acidic alcohol 
hydroxyl groups produce equilibria that lie further toward the Zn-OR species. For example, 
p-methoxyphenol (pKa = 10.2)40 produces an equilbrium that lies toward the Zn-OR 
product (K = 4.2(9) at 300 K), whereas aliphatic alcohols (pKa > 15) produce equilibria that 
lie significantly toward the reactants (K = 10-3-10-5 at 300 K). The hydroxyl group of 
PhCH(OH)C(O)SCD3 should have a lower pKa than benzyl alcohol (pKa = 15) due to the 
presence of the electron withdrawing thioester functionality. The K1 values determined 
from fitting of the saturation curves at pH = 7.0 – 9.0 (Figure 2-5) have large error bars 
(e.g. K1 = 42(24) at pH = 9.0) which precludes a detailed interpretation. However, the 
similarity of this proposed pathway to that outlined for borate-promoted thioester 
hydrolysis lends additional support to the proposed Zn-OR formation. 
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 With regard to possible Fe(III)-SCD3 interactions, for all of the pH values 
examined for the thioester hydrolysis reaction promoted by 1, the disulfide D3CSSCD3 is 
produced in the reaction mixture. This suggests the formation of a Fe(III)-SCD3 species 
that can undergo redox reactivity. A decrease in the intensity of the g = 4.3 signal observed 
at pH = 9.0 (Figure 2-9) suggests the possible reduction of a portion of the Fe(III) to Fe(II) 
during the course of the single turnover reaction,41 albeit this change in intensity may also 
indicate a perturbation in the electronic structure of the iron center, as the intensity of the g 
= 4.3 line is sensitive to the precise value of the axial ZFS parameter (D). We propose that 
the formation of the Fe(III)-SCD3 species provides a rationale for why mandelate anion 
does not coordinate to the Fe(III)Zn(II) complex following thioester hydrolysis. Our 
control experiments indicate that free CD3S- anion in the reaction mixture at pH = 9.0 is 
quickly prontonated to produce CD3SH. However, during the thioester hydrolysis reaction, 
we propose that CD3S- is generated in close proximity to the Fe(III) center thus enabling 
the formation of Fe(III)-SCD3, which subsequently undergoes either redox to produce 
CD3SSCD3, or protonation to release CD3SH. 
 
Conclusions and Prospects 
 We have demonstrated that the Fe(III)Zn(II) complex 1 promotes thioester 
hydrolysis in a pH dependent reaction that achieves maximal rate above the pKa of the Zn-
OH2 moiety. Formation of a novel zinc alkoxide species via deprotonation of the α-
hydroxythioester is proposed at pH values wherein the maximum rate of thioester 
hydrolysis is obtained. Products generated in the reaction include both a thiol and a 
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disulfide, the latter of which indicates the involvement of redox activity that is likely 
derived from a Fe(III)-SCD3 species.   
 The studies outlined herein have particular relevance to glyoxalase II enzymatic 
reactions, as the thioester substrate employed contains a α-hydroxy group and an aliphatic 
leaving group (-SCD3) akin to the aliphatic glutathione-containing substrate hydrolyzed by 
glyoxalase II enzymes. In this regard, this model study is rare in terms of the use of a 
substrate that is not an activated nitro-substituted compound.25 
 This initial study sets the stage for follow up investigations using a similar 
approach (-SCD3 labeled thioester and 2H NMR as a monitoring tool) to examine the 
thioester hydrolysis reactivity of complexes having other binuclear metal combinations, or 
mononuclear zinc complexes. With regard to the latter, Crowder, et al. recently reported 
that human glyoxalase II contains an Fe(II)Zn(II) center but that it is active as a 
mononuclear Zn(II) enzyme.3a The monozinc form would have (His)3 ligation for the 
Zn(II) center (occupying the M1 site) and thus may have multiple solvent-occupied 
coordination positions for possible nucleophile and/or thioester substrate coordination. 
While activated ester hydrolysis reactivity involving mononuclear zinc complexes has been 
extensively investigated,25 thioester reactions have been only minimally investigated to 
date.16 Overall, our novel approach of using a deuterium-labeled aliphatic thioester and 2H 
NMR to monitor hydrolysis reactions opens a window of opportunity into studies of metal 
complex-promoted thioester hydrolysis reactions of relevance to glyoxalase II enzymes. 
Understanding the mechanism of catalysis of glyoxalase II enzymes is an important goal as 
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the glyoxalase pathway is being actively investigated with regard to its role in the clinical 
complications of diabetes, Alzheimer’s disease, oxidative stress, and cancer.42 
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CHAPTER 3 
THIOESTER HYDROLYSIS PROMOTED BY A MONONUCLEAR ZINC COMPLEX* 
 
Abstract 
The mononuclear zinc complex [(bpta)Zn](ClO4)2⋅0.5H2O promotes the hydrolysis 
of the thioester PhCH(OH)C(O)SCD3 when dissolved in CH3CN:H2O (50:50 buffered at 
pH = 9.0). This reaction results in the formation of a mixture of CD3SH and a zinc thiolate 
complex, the latter of which can be protonated to generate additional CD3SH. Kinetic 
studies revealed an overall second-order reaction with an activation energy that is similar to 
that found for aqueous OH- promoted thioester hydrolysis. These studies represent the first 
investigation of chemistry relevant to that occurring in the monozinc-containing form of 
human glyoxalase II. 
 
Introduction 
The glyoxalase pathway is ubiquitous in biological systems and involves two 
metalloenzymes, glyoxalase I (GlxI) and glyoxalase II (GlxII), with glutathione as an 
essential cofactor.1 GlxI catalyzes the isomerization of a hemithioacetal of methyl glyoxal 
to a thioester, and GlxII then catalyzes the hydrolysis of the thioester to produce non-toxic 
products. The glyoxalase pathway is involved in cellular detoxification and is important in 
preventing the formation of advanced glycation end products, which are linked to aging 
and various diseases.2 Because of its critical role in cellular detoxification, the glyoxalase 
system is under investigation as a possible antitumor and antibacterial target.3  
                                                
* Coauthored by James J. Danford, Atta M. Arif, and Lisa M. Berreau. 
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Crowder and coworkers recently reported that human glyoxalase II contains an 
Fe(II)Zn(II) center, but is catalytically active as a mononuclear zinc enzyme.4 This is 
similar to the reactivity found for some metallo-β-lactamases, which catalyze the 
hydrolytic ring-opening of β-lactam antibiotics.5 In the monozinc form of both enzymes, a 
(His)3Zn site catalyzes the hydrolysis of the substrate. While the reactivity of a 
mononuclear Zn-OH complex with the β-lactam-containing nitrocefin has been 
investigated,6 there are no reports in the literature of detailed studies of a thioester 
hydrolysis reaction involving a mononuclear zinc complex. Such studies would have 
relevance to human glyoxalase II. Additionally, these investigations have relevance to a 
recently reported Zn-OH-promoted hydrolysis of the thioester compound thiocoumarin 
within the active site of carbonic anhydrase (CA). This reaction results in the formation of 
a ring-opened product that is a nanomolar inhibitor of three CA isozymes.7 
 
Experimental  
 General Synthetic Methods.  All reagents and solvents were obtained from 
commercial sources and were used as received unless otherwise noted.  The ligand N,N-
bis(2-pyridylmethyl)-tert-butylamine (bpta) was prepared as previously described with 
minor modifications.8 The model thioester substrate hydroxyphenyl-thioacetic acid-S-d3-
methyl ester (PhCH(OH)C(O)SCD3) was prepared according to literature procedures.9  
Physical Methods.  1H and 13C{1H} NMR spectra were recorded on a JEOL 
ECX300 or a Bruker ARX400 spectrometer. Chemical shifts (in ppm) are referenced to the 
residual solvent peaks(s) in CD3CN (1H: 1.94 (quintet); 13C{1H} 1.39 (heptet)). 2H NMR 
spectra for characterization purposes were recorded on a Bruker ARX400 at 61.4 MHz as 
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previously described10 and were referenced to an internal standard of C6D6 (2H: 7.16 
(singlet)). IR spectra were recorded on a Shimadzu FTIR-8400 spectrometer as KBr pellets.  
MALDI mass spectra were obtained from the University of California, Riverside.  
Elemental analysis was performed by Atlantic Microlabs of Norcross, GA. 
Caution! Perchlorate salts of metal complexes with organic ligands are potentially 
explosive.  Only small amounts of material should be prepared and these should be 
handled with great care.11 
[(bpta)Zn](ClO4)2·0.5H2O (1). To a methanol solution (~1 mL) of bpta (18 mg, 
0.071 mmol) was added a methanol solution (~1 mL) of Zn(ClO4)2•6H2O (26 mg, 0.070 
mmol).  The resulting clear, colorless solution was stirred at room temperature for ~1 hour.  
To this solution was added excess Et2O.  The resulting solution was cooled to 4 oC for 24 
hours. The clear solid that had deposited was dried and then recrystallized from CH3CN via 
Et2O diffusion. This yielded clear, colorless plates of 1 suitable for single X-ray diffraction 
analysis (22 mg, 60%). Anal Calc. for C16H22N3O8.5Cl2Zn: C, 36.50; H, 4.22; N, 7.99.  
Found: C, 36.32; H, 4.30; N, 8.01. 1H NMR (CD3CN, 300 MHz) δ 8.73-8.71 (d, J = 5.4 Hz, 
2H), 8.11-8.09 (td, J1 = 1.7 Hz, J2 = 7.5 Hz, 2H), 7.66-7.61 (t, J = 6.3 Hz, 2H), 7.58-7.55 
(d, J = 8.3 Hz, 2H), 4.57-4.51 (d, J = 17.2 Hz, 2H), 3.94-3.88 (d, J = 17.5 Hz, 2H), 1.13 (s, 
9H); 13C{1H} NMR (CD3CN, 100 MHz): δ 158.0, 148.0, 142.6, 125.7, 124.8, 61.5, 55.9, 
26.3 (8 signals expected and observed); FTIR (KBr, cm-1): 3440 (br, vO-H), 1620, 1103 
(vClO4), 633 (vClO4).  MALDI-MS (MeOH) [m/z (relative intensity)]: 418 [(M-H2O-ClO4)]+.   
X-ray Crystallography.  A crystal of 1⋅2CH3CN⋅0.5H2O was mounted on a glass 
fiber using a viscous oil.  The sample was then transferred to a Nonius KappaCCD 
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diffractomer with Mo Kα radiation (λ = 0.71073 Å) for data collection at 150(1) K.  An 
initial set of cell constants was obtained from ten frames of data that were collected with an 
oscillation range of 1 deg/frame and an exposure time of 20 sec/frame. Indexing and unit 
cell refinement based on all observed reflections from those ten frames indicated an 
orthorhombic P lattice. Final cell constants were determined from a set of strong reflections 
from the actual data collection. These reflections were indexed, integrated, and corrected 
for Lorentz, polarization, and absorption effects using DENZO-SMN and SCALEPAC.12 
The structure was solved by a combination of direct methods and heavy atom using SIR 
97.13 All of the non-hydrogen atoms were refined with anisotropic displacement 
coefficients. The hydrogen atoms of the coordinated water molecule were located and 
refined independently. All other hydrogen atoms were assigned isotropic displacement 
coefficients U(H) = 1.2U(C) or 1.5U(Cmethyl), and their coordinates were allowed to ride on 
their respective carbons using SHELXL97.14 Three oxygen atoms of one perchlorate anion 
are each disordered over two positions (0.64:0.36).   
Product Identification in Reactions of 1 with PhCH(OH)C(O)SCD3. Solutions 
comprised of acetonitrile (0.30 mL), CHES buffer (0.36 M, 0.30 mL), distilled water (0.15 
mL), and 1 (0.0019-0.027 M) were prepared. To each solution was added hydroxyphenyl-
thioacetic acid S-d3-methyl ester (0.15 mL of a 0.011 M solution). Each reaction was 
monitored by 2H NMR until the thioester was completely consumed. In reaction mixtures 
having [1]:thioester ratios of >5:1, primarily one product with a –SCD3 resonance at 1.77 
ppm was generated. For reaction mixtures having lower [1]:thioester ratios (1.05:1 and 
lower), two products were identified, having chemical shifts of 2.12 and 1.77 ppm, 
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respectively. The species at 2.12 is CD3SH as previously determined.15 The 1.77 ppm 
resonance has been assigned to the formation of a zinc thiolate complex, with a proposed 
formulation of [(bpta)Zn-SCD3(Sol)n]X (Sol = CH3CN or H2O). The formation of a zinc 
thiolate species is supported by the fact that reducing the pH of the final reaction mixture 
wherein this species predominates results in the production of CD3SH. For example, 
treatment of a final reaction mixture derived from an initial [1]:thioester ratio of 10:1 with 
HNO3 to lower the pH to 8.6 resulted in the formation of CD3SH, which was identified by 
2H NMR. Lowering the pH further to 8.3 results in the production of additional CD3SH. 
Alternatively, treatment of a similar reaction mixture with excess CH3I results in the 
formation of [(CD3)S(CH3)2]X (2H NMR 2.59 ppm; X is possibly NO3-, ClO4-, I- or another 
anion present in the mixed aqueous:organic reaction mixture). To verify the identity of this 
proposed sulfonium salt, CD3SCD3 was treated with excess CH3I under identical reaction 
conditions to those employed for the thioester hydrolysis reactions. This control reaction 
also gave a 2H NMR signal at 2.59 ppm.  
We note that isolation and/or further characterization of the proposed zinc thiolate 
complex [(bpta)Zn-SCD3(Sol)n]X is precluded by the nature of the reaction conditions, 
particularly the mixed solvent environment (CH3CN:H2O 50:50), and the presence of buffer 
(CHES) and salt (NaNO3 (0.61 M)). For example, mass spectrometry of the reaction 
mixture is not an option due to the high salt content of the solution. In situ NMR 
experiments (e.g. 13C NMR) are complicated by the presence of signals from the CH3CN  
solvent and CHES buffer. 
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By stoichiometry, the other product generated in the reaction of 1 with 
PhCH(OH)C(O)SCD3 must be mandelate (PhCH(OH)C(O)O-).16 This product has been 
previously identified in reactions of zinc hydroxide complexes with PhCH(OH)C(O)SCD3 
performed in an organic solvent.16 In these reactions, CD3SH is released and the mandelate 
product coordinates to the Zn(II) center.  
Kinetic Studies of the Reactivity of 1 with PhCH(OH)C(O)SCD3 in 
CH3CN:H2O. Kinetic studies of the thioester hydrolysis reaction promoted by 1 were 
monitored and the data was processed as previously described.15  
  
Results and Discussion 
We have previously shown that use of an aliphatic, deuterium-labeled thioester 
(PhCH(OH)C(O)SCD3), with 2H NMR as the monitoring method, is a feasible approach for 
investigating thioester hydrolysis reactions promoted by dizinc and Fe(III)Zn(II) 
complexes.15,16 These studies revealed that the presence of a terminal Zn-OH species 
enhanced thioester hydrolysis reactivity in both types of complexes. In the research 
outlined herein, we have studied thioester hydrolysis promoted by the mononuclear zinc 
complex [(bpta)Zn](ClO4)2⋅0.5H2O (1). Nitrate and triflate analogs of this complex have 
been previously reported.6 However both were prepared in solution, and no structural or 
spectroscopic data was reported. We have fully characterized 1 using elemental analysis, 
1H and 13C NMR, FTIR, mass spectrometry, and X-ray crystallography.17 When crystallized 
from CH3CN/Et2O, the cationic portion exhibits facial coordination of the bpta ligand, with 
two acetonitrile donors and one water molecule completing the coordination sphere  
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Figure 3-1. Cationic portion of [(bpta)Zn(CH3CN)2(H2O)](ClO4)2 (1⋅2CH3CN⋅0.5H2O). 
Hydrogen atoms other than those of the coordinated water molecule have been omitted for 
clarity. Selected bond distances (Å) and angles (°): Zn(1)-N(3) 2.055(2), Zn(1)-O(1) 
2.1103(3), Zn(1)-N(2) 2.130(2), Zn(1)-N(5) 2.185(2), Zn(1)-N(4) 2.221(3), Zn(1)-N(1) 
2.254(2), N(1)-Zn(1)-N(2) 77.48(9), N(2)-Zn(1)-N(3) 100.02(9), N(1)-Zn(1)-N(3) 
80.66(9).  
 
(Figure 3-1). The water ligand is positioned trans to a pyridyl nitrogen, with a Zn-O 
distance of 2.110(3) Å. The two coordinated acetonitrile ligands have Zn-N distances of 
2.221(3) and 2.185(2) Å, respectively. Three distinct Zn-N distances are found involving 
the bpta ligand, with the shortest being Zn(1)-N(3) (2.055 Å), which is trans to the 
coordinated water molecule. Upon crushing and drying of the crystals, the acetonitrile 
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ligands and half of the water is lost, leading to an analytical formulation for the dried solid 
as [(bpta)Zn](ClO4)2·0.5H2O (1).  
Kinetic studies of nitrocefin hydrolysis promoted by [(bpta)Zn](NO3)2·nH2O yielded 
a kinetic pKa of 7.84(2) for the Zn-OH2 moiety.6 For the thioester hydrolysis studies 
reported herein we have performed all reactions at pH = 9.0 to ensure that a Zn-OH species 
is present. Admixture of 1.05 equivalents of 1 and one equivalent of PhCH(OH)C(O)SCD3 
in 50:50 CH3CN:H2O (buffered at pH = 9.0), followed by heating of this solution at 329.5 
K for ~12 h, results in the formation of two –SCD3-containing products as identified by 2H 
NMR (Figure 3-2). The more abundant product has a 2H NMR signal at 1.77 ppm,18 and a 
smaller signal is found at 2.12 ppm. The latter signal corresponds to CD3SH (pKa = 10.4).15 
We note that in the absence of 1, the hydrolysis of PhCH(OH)C(O)SCD3 under identical 
conditions results in the formation of CD3SH as the only sulfur-containing product.15 We 
propose that the species at 1.77 ppm is a zinc thiolate complex, with an analytical 
formulation such as [(bpta)Zn-SCD3(Sol)n]X (sol = H2O or CH3CN).19 The relative amounts 
of CD3SH and the zinc thiolate complex produced in the reaction mixture change as a 
function of the 1:thioester ratio (Figure 3-2), with more of the zinc thiolate species being 
produced in solutions having a higher initial concentration of zinc complex. Using the 10:1 
([1]:thioester) reaction mixture, which following stoichiometric thioester hydrolysis 
contains only a trace amount of CD3SH (Figure 3-2), lowering of the pH to ~8.6 resulted in 
the formation of additional CD3SH (2.12). Further lowering of the pH to 8.3 resulted in 
additional CD3SH being generated. This data is consistent with the presence of a Zn-SCD3  
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Figure 3-2. 2H NMR spectra obtained following hydrolysis of PhCH(OH)C(O)SCD3 
promoted by 1 at pH = 9.0. The species at 2.12 ppm has been identified as CD3SH. The 
resonance at 1.77 ppm is proposed to be the signal for [(bpta)Zn(SCD3)(Sol)n]X (Sol = 
CH3CN or H2O; X = anion present in solution).  
 
complex that can undergo protonation to release CD3SH. Additional evidence that the 1.77 
ppm species contains a Zn-SCD3 moiety comes from treatment of the reaction mixture with 
excess CH3I, which results in the formation of the sulfonium salt [(CD3)S(CH3)2]X (2H 
NMR 2.59 ppm). 
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Figure 3-3. Plot of kobs (s-1) versus [1] for 299.5 – 329.5 K.  
 
 
At pH = 9.0, the thioester hydrolysis reaction promoted by 1 is catalytic, with 10 
turnovers requiring ~12 days to go to completion at 329.5 K. Monitoring of the loss of 
thioester as a function of time at specific concentrations of 1 yielded plots from which 
pseudo-first-order rate constants (kobs) were determined.20 Varying of the concentration of 1 
from 1.9 to 27 mM, with [PhCH(OH)C(O)SCD3] = 1.8 mM, produced linear plots of kobs 
versus [1] from which second-order rate constants (k2) were determined (Figure 3-3; Table 
3-1). Variable temperature studies in the range of 299.5 - 329.5 K, and construction of an 
Eyring plot (Figure 3-4), yielded ΔH‡ = 13.6(6) kcal/mol, ΔS‡ =  -25.5(2.0) cal/mol·K, and 
Ea = 14.1(6) kcal/mol. 
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Table 3-1. Rate constants for the hydrolysis of PhCH(OH)C(O)SCD3 promoted by 1.a 
    
a[PhCH(OH)C(O)SCD3] = 0.0018 M;  
[1] = 0.0019 – 0.027 M; 50:50 CH3CN:H2O  
(CHES buffer, 0.36 M, I = 0.61 M (NaNO3)) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4. Eyring plot for the hydrolysis of PhCH(OH)C(O)SCD3 promoted by 1 in the 
temperature range of 299.5 – 329.5 K. 
Temperature (K) k2 (M-1s-1) 
299.5 1.87(26) x 10-3 
309.5 4.69(24) x 10-3 
319.5 1.06(11) x 10-2 
329.5 2.44(6) x 10-2 
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The kinetic data for the hydrolysis of PhCH(OH)C(O)SCD3 promoted by 1 revealed 
that the reaction is second-order overall with an associative type mechanism that likely 
involves nucleophilic attack of the Zn-OH moiety on the thioester, with no formation of a 
precursor complex (Scheme 3-1). This differentiates thioester hydrolysis promoted by the 
mononuclear zinc complex from that found for a Fe(III)Zn(II) complex, which mimics a 
common binuclear core found in glyoxalase II enzymes.15 In reactions involving the 
Fe(III)Zn(II) complex, saturation kinetic behavior was interpreted as indicating 
coordination of the deprotonated α-hydroxy group of the thioester to the Zn(II) prior to 
nucleophilic attack by an Fe(III)-OH moiety (Scheme 3-1). We propose that the lack of 
thioester coordination to 1, and the observation of a simple second-order reaction, is due to 
differences in the pKa values of the Zn-OH moieties of 1 and the Fe(III)Zn(II) complex, 
with the latter being a better base (Zn-OH2, kinetic pKa = 8.8),15 thus enabling 
deprotonation of the thioester hydroxyl group. The thioester hydrolysis reaction promoted 
by the Fe(III)Zn(II) complex is >15-fold faster than the reaction performed under identical 
conditions using 1.15 Thus, the equilibrium coordination of the deprotonated thioester to the  
Zn(II) center of the Fe(III)Zn(II) complex facilitates the hydrolysis reaction by positioning 
the thioester carbonyl for nucleophilic attack by the Fe(III)-OH moiety. In terms of leaving 
group stabilization, for the reaction involving the Fe(III)Zn(II) complex, thiolate 
coordination was proposed to occur at the Fe(III) center on the basis of the formation of a 
disulfide side product that likely results from redox chemistry involving an Fe-SCD3 
moiety. For the thioester hydrolysis reaction promoted by 1, the thiolate leaving group is 
stabilized via zinc coordination. For both systems, catalytic turnover presumably occurs via  
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Scheme 3-1. Comparison of the thioester hydrolysis reaction pathways involving binuclear 
Fe(III)Zn(II) and mononuclear Zn(II) complexes. 
 
 
protonation of the M-SCD3 species and generation of the reactive metal-hydroxide species. 
The proposed pathway for the thioester hydrolysis reaction promoted by 1 is shown in 
Scheme 3-2.  
 We note that the activation energy for the thioester hydrolysis reaction promoted by 
1 is similar to that found for the alkaline hydrolysis of n-butylthioacetate.21 This suggests 
that both reactions proceed via rate-determining nucleophilic attack of hydroxide (either 
free or zinc-bound) on the thioester carbonyl carbon. Similar results have been reported for 
the hydrolysis of 4-nitrophenylacetate promoted by OH- or mononuclear zinc complexes 
(Table 3-2).22,23 
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Scheme 3-2. Thioester hydrolysis promoted by 1. 
 
 
Table 3-2. Activation energies for OH- and Zn-OH promoted thioester and ester hydrolysis 
reactions.  
 
Nucleophile Thioester or ester Ea (kcal/mol) 
OH-a n-BTAb 13.9c 
1d TEe 14.1(6) 
OH-h 4-NPAf 10.3(1) 
[([12]aneN3)Zn-OH]ClO4g 4-NPA 11.7(1) 
[([12]aneN4)Zn-OH]ClO4h 4-NPA 10.8(1) 
    
aRef. 21. bn-BTA = n-butylthioacetate. cTemperature = 298 K. dThis work. 
eTE = PhCH(OH)C(O)SCD3. f4-NPA = 4-nitrophenylacetate. gRef. 22. hRef. 23. 
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In summary, we report studies of thioester hydrolysis promoted by a mononuclear 
zinc complex in a mixed organic:aqueous environment. This reaction is relevant to the 
chemistry of the monozinc-containing form of human GlxII. In considering the results of 
this study in combination with those derived from an investigation involving a Fe(III)Zn(II) 
complex,15 it appears that the reaction pathway for the hydrolysis of an α-hydroxythioester 
akin to the GlxII substrate is influenced by the pKa of the Zn-OH2 moiety. Further 
investigations to test this hypothesis are currently in progress. Additionally, our results 
provide evidence to support the notion that Zn-OH promoted ester and thioester hydrolysis 
reactions can proceed via similar reaction pathways. This is relevant to the hydrolysis of 
coumarin and thiocoumarin derivatives within the active site of CA enzymes. 7 
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CHAPTER 4 
FUNDAMENTAL INVESTIGATIONS INTO THE EFFECT OF METAL HALIDES ON 
THE CHEMISTRY OF GLUCOSE IN IONIC LIQUIDS 
 
I. Background 
 A sustainable future requires chemical feedstocks which can be obtained from 
renewable resources rather than steadily depleting existing ones (e.g. petroleum).1 In 2002, 
the US DOE Office of Energy Efficiency and Renewable Energy combined its various 
biochemical programs (biofuels, biopower, etc.) into a single biomass program. One of the 
goals of this program was to identify, screen, and test bio-derived chemicals as the new 
feedstocks for the chemical industry. Researchers at the National Renewable Energy 
Laboratory (NREL) and Pacific Northwest National Laboratory (PNNL) evaluated over 
300 compounds, and based on this study, formulated a list of twelve key sugar-derived 
building block molecules (Table 4-1).2 An important molecule for 2,5-furan dicarboxylic 
acids generation, which are polymer building blocks, is 5-hydroxymethylfurfural (HMF, 
Figure 4-1).3,4 Notably, HMF is also of interest for its role in the synthesis of 2,5-
dimethylfuran (DMF, Figure 4-2), a potentially new biofuel.5  
 
 
 
  
 
Figure 4-1. Structure of 5-hydroxymethylfurfural (HMF). 
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Table 4-1. Twelve key sugar-derived building block molecules. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4-2. Structure of 2,5-dimethylfuran (DMF). 
 
 
II. 5-hydroxymethylfurfural (HMF) 
 
a. Synthesis of HMF. HMF is synthesized by acid-catalyzed triple dehydration of 
hexoses (cellulose, glucose, fructose) (Scheme 4-1). The difficulty in the synthesis of HMF 
lies in the numerous side products formed during dehydration process (levulinic acid, 
formic acid, HMF ethers, and insoluble humic acids).6 The exact mechanism for HMF 
O
Building Block Molecules
1.     1,4 diacids (succinic, fumaric and malic)
2.     2,5 furan dicarboxylic acid (HMF)
3.     3-hydroxy propionic acid
4.     aspartic acid
5.     glucaric acid
6.     glutamic acid
7.     itaconic acid
8.     levulinic acid
9.     3-hydroxybutyrolactone
10.   glycerol
11.   sorbitol
12.   xylitol/arabinitol
#
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Scheme 4-1. Synthesis of HMF from hexoses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4-2. Proposed mechanism for HMF formation from fructose. 
 
 
formation from hexoses is not known, however, two pathways for this process have been 
proposed. The first one involves dehydration without ring opening (Scheme 4-2) and the 
second one involves formation of ring-opened intermediates (Scheme 4-3).6 
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Scheme 4-3. Proposed mechanism for HMF formation from fructose involving ring-opened 
intermediates. 
 
 
b. Industrial Uses of HMF. Oxidation of HMF leads to the formation of 2,5-furan  
dicarboxylic acid (FDA) (Scheme 4-4), which is proposed to be an alternative for 
terephthalic acid (Scheme 4-4), a building block molecule used in the synthesis of 
polyethylene terephthalates (PETs).2 The structural similarities of FDA and terephthalic 
acid make FDA a promising starting material for a new generation of polyesters and nylon 
polymers. 
The hydrogenolysis of HMF (Scheme 4-5) leads to formation of 2,5-dimethylfuran 
(DMF), a potentially new biofuel.5 The appeal of this compound is due to its: (1) high 
energy density relative to ethanol (40% higher); (2) stability in air; and (3) insolubility in 
water.  
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Scheme 4-4. Oxidation of HMF to FDA. 
 
 
 
 
 
 
 
Scheme 4-5. Hydrogenolysis of HMF to DMF. 
 
 
c. Conversion of Biomass to HMF. Currently, the industrial use of HMF as a 
chemical feedstock is limited by its high production cost and poor yield.7 Extensive 
research has been conducted to develop new, higher yield catalysts for the synthesis of 
HMF. Over the years, hundreds of catalysts have been evaluated for the aforementioned 
purpose (representative examples are shown in Table 4-2).8 Unfortunately, the use of these 
catalysts has either led to low yields of HMF, or the production of undesired by-products.  
Traditionally, the synthesis of HMF has been focused on acid-catalyzed dehydration 
of simple hexose sugars (glucose and fructose) (Scheme 4-6), however, recent studies have 
shown that lignocellulose biomass (untreated corn stover) and cellulose can be converted to 
O
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Table 4-2. Catalysts used for the synthesis of HMF. 
 
 
 
 
 
 
 
 
 
 
HMF in respectable yields (~48%).9,10 In an effort to minimize the amount of by-products 
formed during the synthesis of HMF, acidic ionic liquids have been utilized.1,10-13 In 2007, 
researchers at PNNL reported the discovery of a new chemical system (Scheme 4-7) which 
is capable of converting glucose into HMF with little to no by-products. It was found that 
the treatment of glucose with 1-ethyl-3-methylimidazolium chloride (EMIMCl) and 
chromium(II) chloride (CrCl2) gave good yields of HMF (~70%). Interesting was the fact 
that replacement of CrCl2 with CrCl3 still yielded significant amounts of HMF (~45%).1 
 Considering the kinetic inertness of chromium(III), these results appear counterintuitive. 
Nevertheless, some researchers have argued that the interconversion between the two 
oxidation states of chromium could account for these results. The incorporation liquids as 
 
Organic Acids Inorganic Acids Salts Lewis Acids Others
Oxalic Acid Phosphoric Acid (NH4)2SO4/SO3 ZnCl2
Ion-exchange 
      resins
Levulinic Acid Sulphuric Acid Pyridine/PO4
3- AlCl3 Zeolites
Maleic Acid Hydrochloric Acid Pyridine/HCl BF3
p-Toluenesulfonic acid Hydroiodic Acid Aluminum salts
ZrOCl2
VO(SO4)2, TiO2
Zr, Cr, Ti, V
 porphyrine
Zr3(PO4)4
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Scheme 4-6. Formation and decomposition reactions of HMF. 
 
 
 
 
 
 
 
 
 
 
Scheme 4-7. Conversion of glucose to HMF.  
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Scheme 4-8. Conversion of cellulose to HMF in the absence of ionic liquids. 
 
solvents for the manufacturing of HMF has become a common approach, of ionic however, 
in 2009, researchers at the University of Wisconsin-Madison reported the conversion of 
cellulose into HMF in the absence of ionic liquids (Scheme 4-8).10 These reports have 
shown that a solution of dimethylacetamide-lithium chloride (DMA-LiCl) is a suitable 
substitute for ionic liquids.  
 
III. Fundamental Chemistry of Ionic Liquids 
a. Ionic Liquids. Ionic liquids (Figure 4-3) were originally described as air and  
water sensitive liquid electrolytes composed entirely of ions, with a melting point below 
100 oC. In the early 1980’s, room-temperature ionic liquids based on the 1-alkyl-3-
methylimidazolium salts were reported.14,15 Later, researchers sought to solve the problems 
of air and water sensitivity by replacing the less stable chloroaluminate anion with the more 
stable tetrafluoroborate.16 The latest generation of ionic liquids has included substituted 
appendages for performing task specific reactions.17 
O
H
O
HO
5-hydroxymethylfurfural
O
O
O
HO
HO
O
OH
OH
OH
OH
25 mol % CrCl2
10 mol % HCl
10 % DMA-LiCl
140 oC
2 hr
Cellulose
33%
 
 
                                        119 
 
 
 
 
 
Figure 4-3. Three generations of ionic liquids. 
 
Over the years, ionic liquids have been used as both solvents and catalysts.14 
According to the transition-state theory, solvents can modify the Gibbs energy of activation 
by differential solvation of the reactants and intermediate(s).14 Work conducted by Hughes 
and Ingold showed that changes in the solvent polarity result in either an increase or 
decrease of the reaction rate. This change is dependent on whether the intermediate(s) is 
more or less polar than the initial reactants.18,19 It is believed that the increase in solvent 
polarity leads to decrease in the activation energy.14 Hence, the use of these highly polar 
ionic liquids allows for an increase in the reactions rate. Of interest to the research 
described herein is the ability of ionic liquids to act as a catalyst.  The next section focuses 
on how ionic liquids affect the stereochemistry of glucose during its conversion to HMF.  
b. Stereochemistry of Glucose in Ionic Liquids. In order to gain insight into the 
chromium-catalyzed conversion of glucose to HMF, investigations of the stereochemistry 
of glucose in ionic liquids have been undertaken. It has been shown that: (1) glucose, in the 
presence of the ionic liquid [EMIM]Cl, exists primarily in the α-anomer form; (2) the 
presence of a metal halide can alter the α/β anomeric ratio; and (3) the presence of an 
additional solvent can influence the α/β anomeric ratio.1,20-22 
Air/Water Sensitive Air/Water Stable Task Specific
N N
AlCl4
-
N N
BF4
-
N NEtS
PF6
-
2
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Researchers at PNNL reported that when glucose is dissolved in [EMIM]Cl only, 
~90% of glucose exists in its α-pyranose form (~92 ppm) and the remaining ~10% is in the 
β-pyranose form (~98 ppm), as determined by 13C NMR.1 Interesting is that upon addition 
of CrCl2 to the reaction mixture, there is a significant change in the α/β ratio to 
approximately 1:1. In 2001, researchers at the University of Notre Dame showed that at 30 
oC and in the presence of water, the composition of D-glucose is ~38% α-pyranose and 
~62% β-pyranose.20 Further research published in 2006, showed that by changing the 
solvent system from water to [BMIM]Cl:DMSO (BMIM = 1-butyl-3-methylimidazolium 
and DMSO being present at 15 wt%) results in a minimal shift in the α/β ratio to ~41% α 
and ~57% β.22 These results show that the α/β anomeric ratio of glucose is highly 
dependent on the reaction conditions. 
c. Role of [EMIM]CrCl3 in Conversion of Glucose to Fructose. It has been 
proposed that during the conversion of glucose to fructose, the metal catalyst [EMIM]CrCl3 
will perform two different reactions: mutarotation and isomerization.  First, [EMIM]CrCl3 
is expected to initiate mutarotation of α-glucopyranose to β-glucopyranose via proton 
transfer (Scheme 4-9).1 This is consistent with the observed change in the α/β anomeric 
ratio upon addition of CrCl2. Next, [EMIM]CrCl3 will affect a formal hydride transfer 
leading to the isomerization of glucose to fructose, followed by dehydration to HMF 
(Scheme 4-10).1 Prior to the work outlined in Chapter 5, no structural data for the complex 
formed when CrCl2 is mixed with [EMIM]Cl has been reported. Since the nature of the 
active catalyst is of interest, we have determined the solid state crystal structure of 
[EMIM]CrCl3. 
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Scheme 4-9. Mutatoration of α-glucopyranose to β-glucopyranose. 
  
 
 
 
 
 
 
 
 
 
Scheme 4-10. Isomerization of glucose to HMF.  
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CHAPTER 5 
SYNTHESIS AND CRYSTALLIZATION OF POLY[1-ETHYL-3-
METHYLIMIDAZOLIUM[TRI-µ-CHLORIDO-CHROMATE(II)]]* 
 
 
Abstract 
 The title compound, {(C6H11N2)[CrCl3]}n, was generated via mixing of the ionic 
liquid 1-ethyl-3-methylimidazolium chloride with CrCl2 in an ethanol/ethyl acetate 
mixture. Crystals were obtained by diffusion of diethyl ether into the solution. In the crystal 
structure, the anions form one-dimensional chains of chloride-bridged, Jahn-Teller 
distorted chromium(II) centers extending along the [1,0,0] direction. The imidazolium 
cations are positioned between the chains.      
 
Introduction 
 Recently, it was shown that at 100°C a solution of CrCl2 in the ionic liquid 1-ethyl-
3-methylimidazolium chloride ([EMIM]Cl) will catalyze the conversion of glucose to 5-
hydroxymethylfurfural (HMF) in 70% yield.1 The proposed active catalyst in this system is 
a compound formulated as [EMIM]CrCl3. While alkali metal, ammonium, and 
tetramethylammonium chromium(II) trihalides have been previously reported in the  
literature, the title compound is the first structurally characterized imidazolium analog.2-7  
The research described herein is focused on the synthesis and crystallization of CrCl2 in 
[EMIM]Cl. This work has relevance to research dealing with renewable energy and HMF 
                                                
*Coauthored by James J. Danford, Atta M. Arif, and Lisa M. Berreau. Reproduced with 
permission from Acta Cryst. 2009, E65, m227. Copyright 2009 International Union of 
Crystallography. 
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production, as we have determined the solid state structure of the proposed active catalyst 
[EMIM]CrCl3.1  
 
Experimental Section 
 General and Synthetic Methods. All reagents and solvents were obtained from 
commercial sources and were used as received, unless otherwise noted. Elemental analyses 
were performed by Atlantic Microlabs Inc., Norcross, GA. 
 [EMIM]CrCl3 (1). Under a N2 atmosphere, a solution of anhydrous CrCl2 (23 mg, 
0.19 mmol) in ethanol (2 ml) was added to solid 1-ethyl-3-methylimidazolium chloride 
([EMIM]Cl) (23 mg, 0.16 mmol). The resulting, teal colored solution was stirred at 
ambient temperature until the entire solid had dissolved. Addition of ethyl acetate (2 ml), 
followed by Et2O diffusion, produced pale yellow crystals suitable for single crystal X-ray 
diffraction analysis. Yield 51.4%. Anal Calcd. for C6H11N2Cl3Cr: C, 26.87; H, 4.14; N, 
10.45.  Found: C, 26.50; H, 4.16; N, 10.26.  
X-ray Crystallography. A crystal of 1 was mounted on a glass fiber using a 
viscous oil. The sample was then transferred to a Nonius KappaCCD diffractometer with 
Mo Kα radiation (λ = 0.71073 Å) for data collection at 150(1) K.  An initial set of cell 
constants was obtained from ten frames of data that were collected with an oscillation 
range of 1 deg/frame and an exposure time of 20 sec/frame. Indexing and unit cell 
refinement based on all observed reflections from those ten frames, indicated a monoclinic 
P lattice and the space group P21/a. Final cell constants were determined from a set of 
strong reflections from the actual data collection. These reflections were indexed, 
integrated, and corrected for Lorentz, polarization, and absorption effects using DENZO-
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SMN and SCALEPAC.8 The structure was solved by a combination of direct methods and 
heavy atom using SIR 97.9 All H atoms were located and refined isotropically using 
SHELXL97.10  
 
 Results 
 Synthesis and Crystallization of Poly[1-ethyl-3-methylimidazolium [tri-µ-
chlorido-chromate(II)]] (1). The title compound, [(C6H11N2)CrCl3]n, was generated via 
mixing of the ionic liquid 1-ethyl-3-methylimidazolium chloride ([EMIM]Cl) with CrCl2 in 
an ethanol/ethyl acetate mixture. Pale yellow crystals suitable for X-ray crystallographic 
analysis were obtained by diffusion of diethyl ether into the solution. Details of the X-ray 
data collection and refinement are given in Table 5-1. Selected bond distances and angles 
are given in Table 5-2. The structure consists of infinite, linear chains of Jahn–Teller-
distorted chromium centers (Figure 5-1) bridged by a facial array of chloride ligands 
(Figure 5-2). Each Cr(II) has four Cr-Cl bonds of approximately 2.39-2.45 Å and two 
longer Cr-Cl interactions (2.87-2.91 Å). The Cr-Cr distance is 3.33 Å and the shortest Cr-
Cr distance between chains is 9.19 Å. The Cl-Cr-Cl bond angles are in the range of 87-90°. 
A number of differences are evident in the structures of [EMIM]CrCl3 (collected at 150 (1) 
K) and the previously reported [N(CH3)4]CrCl3 (collected at room temperature).3 
Specifically, the chromium center in [EMIM]CrCl3 has a pseudo D4h site symmetry, 
whereas [N(CH3)4]CrCl3 contains trigonally distorted chromium centers (C3v site symmetry) 
positioned in alternating compressed and elongated face-sharing octahedra. Similar site 
symmetry to that found in [N(CH3)4]CrCl3 was identified in the room temperature structure 
of α-CsCrCl3.5, 7 This C3v site symmetry is described as resulting from randomly distributed 
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elongation of Cr-Cl bonds along three principal axes of the octahedron. 
 
Conclusion 
A sustainable future requires chemical feedstocks which can be obtained from 
renewable resources rather than steadily depleting ones (e.g. petroleum).1 Recently, HMF 
(Figure 5-3) has become an extremely important feedstock molecule because of its 
potential to act as both a biofuel and a polymer precursor. Industrial use of HMF as a 
chemical intermediate is limited by high production costs and poor yields.11 However, 
extensive research has been conducted toward the development of new methods for 
converting renewable biomass into HMF, with increased yields and decreased costs. In 
2007, researchers at Pacific Northwest National Laboratories (PNNL) reported the 
discovery of a novel chemical system (Scheme 5-1) which is capable of converting glucose 
into HMF with little to no by-products.1 The proposed active catalyst in this system is a 
compound formulated as [EMIM]CrCl3. It was found that treatment of glucose with the 
ionic liquid 1-ethyl-3-methylimidazolium chloride ([EMIM]Cl) and chromium(II) chloride 
(CrCl2) gives good yields of HMF (~70%).1 However, the exact composition present 
during the conversion of glucose to HMF remains unidentified. Our goal was to synthesize 
and crystallize this proposed active catalyst. We were successful in providing a solid state 
crystal structure of [(C6H11N2)CrCl3]n. In the crystal structure, anions form one-
dimensional chains of chloride-bridged Jahn-Teller distorted chromium(II) centers 
extending along the [1,0,0] direction. The imidazolium cations are positioned between 
these chains. Further studies aimed at elucidating how the metal halide and ionic liquid 
affect the structure of this complex are being pursued. 
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Table 5-1. Summary of X-ray data collection and refinement of 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Empirical formula
Largest diff. (e Å-3)
Goodness-of-fit (F2)
R1 / wR2b
Formula weight
! range for data collection (deg)
Reflections collected
Indep. Reflections
Variable parameters
Crystal system
Space group
a (Å)
b (Å)
c (Å)
" (deg)
V (Å3)
Z
Density (calcd), Mg m-3
Temp (K)
Crystal size (mm)
Diffractometer
Abs. coeff. (mm-1)
Completeness to !(%)
269.52
Monoclinic
P21/a
6.66150 (10)
16.4317 (4)
9.5258 (2)
90.
1037.56 (4)
4
1.725
150 (1)
0.25 x 0.20 x 0.15
Nonius KappaCCD
1.82
C6H11N2Cl3Cr
2.48 to 27.49
99.7
4056
2384 [R(int) = 0.0181]
154
0.0321 / 0.0642
1.084
0.417 / -0.484
# (deg) 95.6881 (14)
$ (deg) 90.
aRadiation used: Mo K" (% = 0.71073 Å).
bR1 = &( || Fo | - |Fc || ) / & |Fo|, wR2 = [& [w(Fo
2 - Fc
2)2]/& (Fo
2)2]1/2
where w = 1/['2(Fo
2) + (aP)2 + bP].
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Table 5-2. Selected bond lengths (Å) and angles (o) for 1 characterized by X-ray 
crystallography.a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-1. Coordination environment of [(C6H11N2)CrCl3]n. 
Cr(1)-Cl(1)
Cr(1)-Cl(2)
Cl(2)-Cr(1)-Cl(1)
Cl(2)-Cr(1)-Cl(3)
Cl(1)-Cr(1)-Cl(3)
Cl(2)-Cr(1)-Cl(3)i
Cr(1)-Cl(3)
Cr(1)-Cl(3)i
Cl(1)-Cr(1)-Cl(3)i
Cl(3)-Cr(1)-Cl(3)i
Cr(1)-Cl(3)-Cr(1)ii
2.3876 (5)
2.3898 (5)
177.976 (19)
87.073 (15)
91.904 (16)
91.906 (16)
2.4431 (5)
2.4476 (5)
89.027 (15)
176.95 (2)
85.856 (13)
aEstimated standard deviations in the last significant figure are given in parentheses.
 Symmetry codes: (i) x - 1/2, -y + 1/2, z; (ii) x + 1/2, -y + 1/2, z.
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Figure 5-2. One-dimensional chain structure of [(C6H11N2)CrCl3]n extending along [1,0,0]. 
 
   
 
 
 
Figure 5-3. Structure of 5-hydroxymethylfurfural (HMF). 
 
 
 
 
 
 
 
Scheme 5-1. Conversion of glucose to HMF catalyzed by [EMIM]CrCl3.  
O
OH
HO
HO OH
OH
[EMIM]Cl/CrCl2
100 oC
- 3 H2O
O
H
O
HO
5-Hydroxymethylfurfural
N N
EMIM
      D-glucose
!-pyranose form
O
HO
H
O
 
 
 
 
 
            
                                                                                                               131 
References 
1. Zhao, H.; Holladay, J. E.; Brown, H.; Zhang, Z. C. Science 2007, 316, 1597-1600. 
2. Hardt, H. D.; Streit, G. Z. Anorg. Allg. Chem. 1970, 373, 97-110. 
3. Bellitto, C.; Dessy, G.; Fares, V.; Fiorani, D.; Viticoli, S. J. Physics and Chemistry 
of Solids 1984 , 45, 1129-1134. 
4. Crama, W. J.; Bakker, M.; Verschoor, G. C.; Maaskant, W. J. A. Acta 
Crystallographica Section B 1979, 35, 1875-1877. 
5. McPherson, G. L.; J., K. T.; B., F. J.; D., S. G. J. Chem. Phys 1972, 57, 3771-3780. 
6. Crama, W. J.; Maaskant, W. J. A.; Verschoor, G. C. Acta Crystallographica Section 
B 1978, 34, 1973-1974. 
7. Crama, W. J.; Zandbergen, H. W. Acta Crystallographica Section B 1981, 37, 
1027-1031. 
8. Otwinowski, Z.; Minor, W. Methods in Enzymology 1997, 276, 307. 
9. Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, G. L.; Giacovazzo, C.; 
Guagliardi, A.; Moliterni, A. G. G.; Polidori, G.; Spagna, R. J. Applied 
Crystallography 1999, 32, 115-119. 
10. Sheldrick, G. Acta Crystallographica Section A 2008, 64, 112-122. 
11. Roman-Leshkov, Y.; Chheda, J. N.; Dumesic, J. A. Science 2006, 312, 1933-1937. 
 
 





 137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 







